Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1050.Time spend outdoors in summer,48066,0.181700400947412,0.0378154149642027,0.107582187617575,0.25581861427725,1.55733177262212e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1060.Time spent outdoors in winter,44447,0.0875405871453824,0.0431793959248802,0.00290897113261719,0.172172203158148,0.0426375040734415
EPHA2,Ephrin type-A receptor 2,Physical activities,X1070.Time spent watching television (TV),49213,0.198533148754985,0.0377429023149584,0.124557060217666,0.272509237292303,1.45109664602287e-07
EPHA2,Ephrin type-A receptor 2,Physical activities,X1080.Time spent using computer,44391,-0.0436652339442872,0.0397300829207836,-0.121536196469023,0.0342057285804486,0.271760393515271
EPHA2,Ephrin type-A receptor 2,Physical activities,X1090.Time spent driving,43292,-0.24734126545759,0.0425075563142213,-0.330656075833464,-0.164026455081716,6.02174460011666e-09
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1160.Sleep duration,50936,0.0201400202981231,0.035355712565394,-0.0491571763300492,0.0894372169262954,0.568926768477702
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34086,0.00935733643902,0.00980538254425189,-0.0098612133477137,0.0285758862257537,0.339951275244433
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34086,0.00601003310666903,0.00959035863386802,-0.0127870698157123,0.0248071360290503,0.53088661817308
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34086,0.0270432820215861,0.0112983241289975,0.00489856672875108,0.0491879973144211,0.0167034028834236
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34086,0.0265222725127653,0.0118371083229581,0.00332154019976742,0.0497230048257632,0.0250731187451788
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34086,0.0362854764655642,0.0120815009313065,0.0126057346402035,0.0599652182909248,0.00267634740029499
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34086,-0.0189636682924556,0.0230964242308444,-0.0642326597849105,0.0263053231999993,0.411628317743749
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34086,0.0311854852998284,0.023801205042164,-0.0154648765828129,0.0778358471824698,0.190141324879223
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34086,0.017514664372845,0.0167759406432913,-0.0153661792880058,0.0503955080336959,0.296494008972619
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34086,0.0421547206891061,0.0124004637362595,0.0178498117660374,0.0664596296121748,0.000677801937031424
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34086,0.029210061106362,0.00872935553117131,0.0121005242652663,0.0463195979474578,0.000822261097210967
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34086,0.0291417017473541,0.0123761489911484,0.0048844497247032,0.0533989537700051,0.0185581397517068
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34086,0.00901952546026939,0.00712649250672078,-0.00494839985290334,0.0229874507734421,0.205673271700095
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34086,0.00561528675380888,0.00911815460672193,-0.0122562962753661,0.0234868697829839,0.538016551305182
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34086,0.0291626584719976,0.0138637193608569,0.00198976852471817,0.0563355484192771,0.0354444009892371
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34086,0.0331474739689921,0.0131665351836122,0.00734106500911219,0.058953882928872,0.0118324128735842
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34086,0.0152578467943043,0.0163849059084776,-0.0168565687863119,0.0473722623749205,0.351765080912807
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34086,0.00726147128115308,0.015458098705281,-0.0230364021811976,0.0375593447435038,0.638542297581689
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34086,0.00735802958250835,0.0101952528097656,-0.0126246659246323,0.027340725089649,0.470488468885943
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34086,0.0184266619635682,0.00964872503311405,-0.00048483910133534,0.0373381630284717,0.0561932352142253
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34086,0.0242235962274921,0.0119654477127563,0.000771318710489719,0.0476758737444944,0.0429485611826215
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120040.Fatigue severity over the past week,34093,0.155325189103057,0.0624012104092315,0.0330188167009633,0.277631561505151,0.0128211136772045
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34095,0.200098280986516,0.0617221282363141,0.0791229096433402,0.321073652329691,0.00119106945116938
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34094,0.119233459839425,0.0678084988169144,-0.0136711978417268,0.252138117520577,0.0787118842940147
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120098.Mobility problems today,34098,0.408887629573696,0.0756674230973786,0.260579480302834,0.557195778844558,6.67274656208011e-08
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120099.Self-care problems today,34098,0.549269565540059,0.113690631082213,0.326435928618922,0.772103202461196,1.37637169608176e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120100.Problems doing usual activities,34098,0.316953481606239,0.0714132865800153,0.176983439909409,0.456923523303069,9.16216574076263e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120101.Pain or discomfort today,34098,0.212232763824234,0.0627085749575601,0.0893239569074163,0.335141570741052,0.000715940839269579
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120102.Anxiety or depression today,34098,0.168808697859585,0.0737845528434353,0.024190974286452,0.313426421432718,0.0221659964919758
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120103.Scale to indicate how health is today,34066,-0.0108971695737107,0.00307792730625875,-0.0169299070939778,-0.00486443205344352,0.000401263227099799
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34082,0.218428069246838,0.0733827966554014,0.074597787802251,0.362258350691425,0.00292187928765382
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34068,0.134269176543394,0.0754746616383796,-0.0136611602678303,0.282199513354618,0.0752700528196818
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34087,0.106901431731035,0.0614583783511411,-0.0135569898372019,0.227359853299271,0.0819924371597323
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34088,0.135075373045199,0.0628685796761402,0.0118529568799641,0.258297789210434,0.0316946521834162
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34084,0.298094310324228,0.0769128272045879,0.147345169003236,0.448843451645221,0.000106964558782437
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34060,0.0806908123005349,0.0786968633498296,-0.0735550398651312,0.234936664466201,0.305228484095009
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34089,0.21407045885935,0.0785302324108779,0.0601512033340293,0.367989714384671,0.0064223475477108
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34076,0.446859028352744,0.114503912807973,0.222431359249118,0.671286697456371,9.5789618584928e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34023,0.169257487693415,0.153821049739526,-0.132231769796057,0.470746745182887,0.271204318512038
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31191,0.319615037499369,0.0812563597058079,0.160352572475985,0.478877502522752,8.45200866992292e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,47973,0.12355822172841,0.0806504771182132,-0.0345167134232882,0.281633156880108,0.125530380827199
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,46717,0.0128909130046456,0.0508900569612089,-0.0868535986393238,0.112635424648615,0.800031665986926
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1289.Cooked vegetable intake,49962,-0.229073843303748,0.0360659883038756,-0.299763180379344,-0.158384506228152,2.16709259898683e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49435,-0.197529169968885,0.0388367211259637,-0.273649143375774,-0.121409196561996,3.67995891476819e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1309.Fresh fruit intake,49923,0.0793076795629389,0.0385601534052083,0.00372977888873072,0.154885580237147,0.0397224974622888
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1319.Dried fruit intake,48444,-0.0572307972171099,0.0407389486635995,-0.137079136597765,0.0226175421635451,0.160088122035516
EPHA2,Ephrin type-A receptor 2,Health and medical history,X134.Number of self-reported cancers,51158,0.515348358189201,0.0732004701278183,0.371875436738677,0.658821279639725,1.96457359502279e-12
EPHA2,Ephrin type-A receptor 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51158,0.394523559132768,0.0359501845840963,0.324061197347939,0.464985920917597,5.82003415977161e-28
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X136.Number of operations, self-reported",51158,0.156408287803806,0.0351545150928019,0.0875054382219142,0.225311137385698,8.65447778212838e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X137.Number of treatments or medications taken,51158,0.446043873861573,0.0356921662009676,0.376087228107676,0.516000519615469,9.71574244647467e-36
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1438.Bread intake,50327,0.00904998687744543,0.00206612430485609,0.00500038323992749,0.0130995905149634,1.19038977056047e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1458.Cereal intake,49580,0.232147866148459,0.0365901892978462,0.160431095124681,0.303864637172238,2.26806440380009e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1488.Tea intake,50103,0.00492667091593564,0.00195188867459261,0.00110096911373413,0.00875237271813716,0.0116068854897224
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1498.Coffee intake,48908,-0.155132946417143,0.0366236104817919,-0.226915222961455,-0.0833506698728308,2.28478509910564e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1528.Water intake,49214,-0.0516002790726903,0.0372236889261672,-0.124558709367978,0.0213581512225974,0.1656914594405
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1568.Average weekly red wine intake,42361,-0.524772148093523,0.0447893296637362,-0.612559234234446,-0.4369850619526,1.35747711075167e-31
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42353,-0.236779873508925,0.0455886627588134,-0.326133652516199,-0.147426094501651,2.08192877074228e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,42399,-0.0702398029831795,0.0492584885721116,-0.166786440584518,0.0263068346181592,0.153901599194497
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1598.Average weekly spirits intake,42323,-0.062497178654601,0.0494670798977883,-0.159452655254266,0.0344582979450641,0.206458005873305
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1608.Average weekly fortified wine intake,42391,0.123055440510655,0.0882234762207378,-0.049862572881991,0.295973453903301,0.163088310700472
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1737.Childhood sunburn occasions,44860,-0.121600913615709,0.0423746209921792,-0.20465517076038,-0.0385466564710373,0.00411318579742049
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1807.Father's age at death,40153,-0.00220578046157511,0.00277569990181239,-0.0076461522691274,0.00323459134597719,0.426813914049387
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1845.Mother's age,39389,-0.00767918006906433,0.00412796326772346,-0.0157699880738023,0.00041162793567366,0.0628643820560945
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1873.Number of full brothers,50682,-0.008860868210482,0.0353504921057968,-0.0781478327378437,0.0604260963168797,0.802080793001581
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1883.Number of full sisters,50683,0.0208736375856603,0.0352919900607587,-0.0482986629334268,0.0900459381047474,0.554220324303624
EPHA2,Ephrin type-A receptor 2,Physical measures,X20015.Sitting height,50942,0.00341493158183796,0.00261449952052163,-0.00170948747838443,0.00853935064206035,0.191512251229373
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20016.Fluid intelligence score,32516,-0.0571713568093131,0.0601805892478978,-0.175125311735193,0.0607825981165666,0.342140526172694
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20018.Prospective memory result,32831,0.152427146683927,0.0832835712039496,-0.0108086528758143,0.315662946243668,0.0672504124128317
EPHA2,Ephrin type-A receptor 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32431,0.00853559011475257,0.00359760574843708,0.00148428284781589,0.0155868973816893,0.017686509281208
EPHA2,Ephrin type-A receptor 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32425,0.0113995279760525,0.00357723205945633,0.00438815313951811,0.0184109028125869,0.00144427911601141
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20023.Mean time to correctly identify matches,50861,0.00855021771415166,0.00208733152118587,0.00445904793262736,0.012641387495676,4.21132420817901e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48016,-0.00394070573491168,0.00450096557526779,-0.0127625982624366,0.0048811867926132,0.381297278847423
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,47600,-0.00583538036937091,0.0101890463452538,-0.0258059112060683,0.0141351504673264,0.566845715841846
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47566,0.0013699005639869,0.0137565423768058,-0.0255929224945525,0.0283327236225263,0.920677225214744
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,47596,-0.00412318868349904,0.0105610841143749,-0.0248229135476738,0.0165765361806757,0.696234389408529
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,47598,0.00792466752824684,0.0076727099740359,-0.00711384402086353,0.0229631790773572,0.301690172219342
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#2.Illnesses of father_Stroke,47759,-0.0082621629248406,0.00590654557216425,-0.0198389922462825,0.00331466639660133,0.161881526194714
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,47698,-0.00619012302898419,0.00768441098797741,-0.0212515685654199,0.00887132250745153,0.420514471902903
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,47603,0.0136230482042071,0.00924491026009604,-0.0044969759055811,0.0317430723139954,0.140609909148999
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,47719,0.00345754555104349,0.00731625676224756,-0.0108823177029617,0.0177974088050487,0.636514355055526
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,47874,-0.00128981598854041,0.00465450971354236,-0.0104126550270834,0.00783302305000262,0.781697236568437
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,47722,0.00207679125139546,0.00635250360449318,-0.0103741158134112,0.0145276983162021,0.743727597249041
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49045,0.00920591552527574,0.00542312478644052,-0.00142340905614767,0.0198352401066992,0.0896089110347226
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,48917,-0.00962102535855735,0.00878184372735599,-0.0268334390641751,0.00759138834706038,0.273282470676957
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,48863,0.015109971437132,0.0182627033916521,-0.0206849272105062,0.0509048700847702,0.408036561847605
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,48906,0.0154196441707053,0.00791452986225093,-9.28343593064838e-05,0.0309321227007172,0.0513937719652398
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,48992,0.00747878805637525,0.00642468454597159,-0.00511359365372906,0.0200711697664796,0.24440634763293
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,48911,-0.00886673515578348,0.01044813582648,-0.0293450813756843,0.0116116110641173,0.396088197182769
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,48891,-0.00959940423052513,0.0100298386882334,-0.0292578880594625,0.0100590795984122,0.338533795306011
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,48924,0.0134915588305021,0.00751473074888591,-0.00123731343731425,0.0282204310983185,0.0726102714168199
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,48926,0.0337456105944357,0.00882607872635429,0.0164464962907813,0.0510447248980901,0.000131943474265144
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49137,-0.000263219838024309,0.0042639114590785,-0.00862048629781817,0.00809404662176955,0.950776733891347
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,48981,0.016748465558435,0.00660794985783834,0.00379688383707184,0.0297000472797981,0.0112638117967193
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46280,0.00308917836044628,0.00857901257719651,-0.0137256862908589,0.0199040430117514,0.718786559201835
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46168,0.0223519283363615,0.0470902054556241,-0.0699448743566617,0.114648731029385,0.635032595415321
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46166,-0.0313930790937397,0.0416134296422796,-0.112955401192608,0.0501692430051282,0.450618365949814
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46250,0.00564500965521735,0.0078503634319283,-0.00974170267136213,0.0210317219817968,0.472101463411209
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46173,-0.0150556383386998,0.0264338243435025,-0.0668659340519648,0.0367546573745651,0.568982172040791
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46184,0.048416996949602,0.0148601940472671,0.0192910166169586,0.0775429772822455,0.00112301868036851
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46175,0.00691826359168176,0.0197880819467884,-0.0318663770240236,0.0457029042073871,0.726628928869154
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46183,-0.00190566002016927,0.0176569218599798,-0.0365132268657297,0.0327019068253911,0.914054505724756
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46186,0.0252282928718284,0.0119311404588431,0.001843257572496,0.0486133281711609,0.0344843788583854
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46191,0.0372629114415618,0.0154720272638885,0.00693773800434038,0.0675880848787832,0.0160304341756818
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46367,0.00541309464995621,0.00552085761772998,-0.00540778628079456,0.016233975580707,0.326859403297505
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46262,0.0194345318839996,0.0080579998656349,0.00364085214735516,0.035228211620644,0.0158806356930439
EPHA2,Ephrin type-A receptor 2,Mental health,X20127.Neuroticism score,45773,0.148986536934809,0.0370329847853155,0.0764018867555908,0.221571187114028,5.76355700141923e-05
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32516,-0.0059090455274186,0.0611954985557827,-0.125852222696753,0.114034131641916,0.923077955400315
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20161.Pack years of smoking,31392,0.0167721907185498,0.00443727284196581,0.00807513594829683,0.0254692454888028,0.000158139785704184
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31392,0.0149267499833757,0.00414868043230861,0.00679533633605088,0.0230581636307006,0.000322791169706262
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20191.Fluid intelligence score,31133,0.0188220552919172,0.0651479001180143,-0.108867828939391,0.146511939523225,0.772656437559062
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31133,-0.00251007697943199,0.0665110380906051,-0.132871711637018,0.127851557678154,0.969896615357654
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20240.Maximum digits remembered correctly,30506,-0.0921718530528022,0.0685767175641204,-0.226582219478478,0.0422385133728738,0.178971948903428
EPHA2,Ephrin type-A receptor 2,Physical measures,X20255.Spirometry QC measure,44264,0.071111332463739,0.0471011552906715,-0.0212069319059771,0.163429596833455,0.131120742084225
EPHA2,Ephrin type-A receptor 2,Eye measures,X20261.avMSE,29764,0.00283790739745433,0.00444505698716494,-0.00587440429738896,0.0115502190922976,0.523211299772261
EPHA2,Ephrin type-A receptor 2,Eye measures,X20262.Myopia diagnosis,29764,0.0741653275547098,0.0881114515745954,-0.0985331175314971,0.246863772640917,0.399977803715663
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20280.Glucose-lactate,39211,0.00147565528400641,0.00271153241932248,-0.00383894825786564,0.00679025882587846,0.586301772965306
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39245,0.00986384962000918,0.00267150341669053,0.00462770292329574,0.0150999963167226,0.000223050123380856
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32332,-0.012188690839566,0.0127317101675839,-0.0371428427680304,0.0127654610888984,0.338418415278288
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32329,0.0102349561061332,0.0256669177131205,-0.040072202611583,0.0605421148238494,0.690079647065975
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32327,0.00502951369472103,0.028013370884402,-0.0498766932387068,0.0599357206281489,0.857518202063638
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32327,-0.0280363403243194,0.0123236409077451,-0.0521906765034998,-0.00388200414513904,0.0229305400815456
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32327,-0.0551846813385094,0.0197845272105159,-0.0939623546711206,-0.0164070080058982,0.00529426039790971
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32334,-0.0103978984470807,0.0258475611547147,-0.0610591183103215,0.0402633214161601,0.687489782479795
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32334,-0.0253933091233607,0.0168116326453359,-0.058344109108219,0.00755749086149765,0.130963215446154
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32334,-0.0236448395422559,0.0183282960742144,-0.0595682998477162,0.0122786207632044,0.197060523028056
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32334,0.00123806007978149,0.0290905942785947,-0.0557795047062641,0.0582556248658271,0.966054260531911
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32334,0.0528201928480728,0.0338636294741284,-0.0135525209212188,0.119192906617364,0.118846563563198
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32334,-0.0107341132639489,0.0190336472688631,-0.0480400619109207,0.0265718353830228,0.572799942426563
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32334,0.0483096361320035,0.0324956815087784,-0.0153818996252022,0.112001171889209,0.137145038041994
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32334,0.0107209612199587,0.0252298372703904,-0.0387295198300064,0.0601714422699238,0.67089715075108
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32338,0.0191198177534506,0.0329753565176119,-0.0455118810210687,0.08375151652797,0.562050464815905
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32338,-0.0126836092365875,0.0162535073509706,-0.0445404836444899,0.0191732651713148,0.435199986407632
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32338,-0.0418290229575126,0.0225527400861204,-0.0860323935263085,0.00237434761128336,0.0636708858238706
EPHA2,Ephrin type-A receptor 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32337,-0.000917562817747358,0.0370382805376864,-0.0735125926716127,0.071677467036118,0.98023631983438
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20600.Liking for adding salt to foods,34933,-0.0286728808865993,0.0546393763813677,-0.13576605859408,0.0784202968208814,0.599756461528565
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20601.Liking for aniseed,34933,-0.0724262239722915,0.0543475680851208,-0.178947457419128,0.0340950094745452,0.182674510751195
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20602.Liking for apple juice,34933,0.114015697461921,0.0551175699426842,0.00598526037425964,0.222046134549582,0.038607679025628
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20603.Liking for apples,34933,0.00671924088126757,0.0562793082468482,-0.103588203282555,0.11702668504509,0.904967787177952
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20604.Liking for asparagus,34933,-0.344782139489302,0.0554822289278771,-0.453527308187941,-0.236036970790663,5.34151571582231e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20605.Liking for aubergine,34933,-0.343916864026787,0.0545195157931725,-0.450775114981405,-0.237058613072169,2.93187002185169e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20606.Liking for avocados,34933,-0.345705770472963,0.0555340274503261,-0.454552464275602,-0.236859076670324,4.98630283426604e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20607.Liking for bacon,34933,-0.132093350883278,0.0549649717389654,-0.23982469549165,-0.0243620062749053,0.0162674130503478
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20608.Liking for baked or steamed fish,34933,-0.308086333671415,0.0557236778752244,-0.417304742306854,-0.198867925035975,3.29701917465102e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20609.Liking for bananas,34933,0.145047329114797,0.0566137352554139,0.0340844080141855,0.256010250215408,0.0104186995302532
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,34933,-0.284362008114719,0.0547819704919639,-0.391734670278968,-0.176989345950469,2.13110528371014e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20611.Liking for beef steak,34933,-0.24051825543476,0.0553695253315244,-0.349042525084548,-0.131993985784973,1.41239245663097e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20612.Liking for beetroot,34933,-0.144413960719611,0.0556399200945812,-0.25346820410499,-0.0353597173342316,0.00945754377679658
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20613.Liking for bell pepper,34933,-0.245809865027434,0.0550115089622364,-0.353632422593417,-0.137987307461451,7.96135781717605e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20614.Liking for bicycling,34933,-0.0210225279015676,0.0546902645701584,-0.128215446459078,0.0861703906559428,0.700694940947028
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20615.Liking for biscuits,34933,0.349905007334992,0.0549915491993917,0.242121570904184,0.4576884437658,2.05820510981944e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20616.Liking for bitter foods,34933,-0.333476945359432,0.0544033991462811,-0.440107607686143,-0.226846283032721,9.1040262770467e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20617.Liking for bitter or ale,34933,-0.466673074068187,0.0560522494624628,-0.576535483014614,-0.35681066512176,9.37100247670092e-17
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20618.Liking for black olives,34933,-0.341897947336091,0.0552054577846597,-0.450100644594024,-0.233695250078158,6.10507515603272e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20619.Liking for black pepper,34933,-0.259249529925569,0.0554791304554659,-0.367988625618282,-0.150510434232856,3.00451179620982e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20620.Liking for blue cheese,34933,-0.277990649102806,0.0548071824497781,-0.385412726704371,-0.170568571501241,3.99705546720023e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20621.Liking for bolognese sauce,34933,-0.181244061416834,0.0552603501927478,-0.28955434779462,-0.0729337750390487,0.00104194023707087
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20622.Liking for broad beans,34933,-0.16763045532232,0.0555125989933475,-0.276435149349281,-0.0588257612953591,0.00253616424548682
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20623.Liking for broccoli,34933,-0.106520330571769,0.0567062560783132,-0.217664592485263,0.00462393134172488,0.0603447863055861
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20624.Liking for brown rice,34933,-0.10862563038873,0.0547990897076705,-0.216031846215764,-0.00121941456169605,0.047475691439248
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20625.Liking for brussel sprouts,34933,-0.0967831841949743,0.0552607067486089,-0.205094169422248,0.0115278010322991,0.0799060411302354
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20626.Liking for burgers (meat),34933,-0.110857138030904,0.0543779598794901,-0.217437939394704,-0.00427633666710342,0.0415095941602071
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20627.Liking for burn of spicy foods,34933,-0.305359397036014,0.054775176358438,-0.412718742698552,-0.198000051373475,2.53656195393613e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20628.Liking for butter on bread,34933,0.127593963888098,0.0553810053510406,0.0190471934000582,0.236140734376137,0.0212450087980286
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20629.Liking for butternut squash,34933,-0.181433293868389,0.0545805500933317,-0.288411172051319,-0.0744554156854589,0.000889803572451981
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20630.Liking for cabbage,34933,-0.12521432640045,0.0554468899991124,-0.233890230798711,-0.01653842200219,0.0239479144639223
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20631.Liking for cake,34933,0.367644310965617,0.0556130657409168,0.258642702113421,0.476645919817814,3.99963809957997e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20632.Liking for cake icing,34933,0.315745490373197,0.0548722103328661,0.20819595812078,0.423295022625615,8.93656401933581e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20633.Liking for capers,34933,-0.438954986774544,0.0544049805012544,-0.545588748557003,-0.332321224992085,7.86547698273379e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20634.Liking for cauliflower,34933,-0.0982865193439864,0.055831653604651,-0.207716560409102,0.0111435217211295,0.0783661897589318
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20635.Liking for cereal or granola bar,34933,0.077192654731553,0.0547459557112619,-0.0301094184625203,0.184494727925626,0.15856316989798
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20636.Liking for cheesecake,34933,0.15849233874998,0.0547468103427872,0.0511885904781174,0.265796087021843,0.0037989299338374
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20637.Liking for cherries,34933,-0.109510188464221,0.0574623964628112,-0.222136485531331,0.00311610860288844,0.0567057691959579
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20638.Liking for chicken,34933,-0.1927589109719,0.0570317768387452,-0.304541193575841,-0.0809766283679596,0.000727757373867894
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20639.Liking for chilli pepper,34933,-0.333337250776007,0.0547519372932732,-0.440651047870822,-0.226023453681191,1.18021298934192e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20640.Liking for chips or french fries,34933,0.133897991382081,0.0551505665654292,0.0258028809138399,0.241993101850322,0.0152039425783878
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20641.Liking for cigarette smoking,34933,-0.120858081697976,0.0860289300138101,-0.289474784525044,0.0477586211290914,0.160092788372015
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20642.Liking for cod,34933,-0.283857901151995,0.0566946185406973,-0.394979353491761,-0.172736448812228,5.61988757381954e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20643.Liking for coffee with sugar,34933,0.138532734061527,0.0599216460884512,0.0210863077281626,0.255979160394891,0.0208015770213347
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20644.Liking for coffee without sugar,34933,-0.226930760140473,0.0553082586157243,-0.335334947027293,-0.118526573253654,4.10719241693069e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20645.Liking for coriander,34933,-0.304044022589007,0.0553972298766619,-0.412622593147264,-0.19546545203075,4.14453897129282e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20646.Liking for corn flakes,34933,0.312421677900087,0.0543842770414864,0.205828494898774,0.419014860901401,9.45093540643784e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20647.Liking for cream,34933,0.114291832812542,0.0545754207842732,0.00732400807536694,0.221259657549718,0.0362648839800855
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20648.Liking for croissant,34933,0.146284736393665,0.0547462893280229,0.0389820093107402,0.25358746347659,0.0075500218578066
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20649.Liking for cucumber,34933,-0.0426750906793277,0.0553220711736231,-0.151106350179629,0.0657561688209736,0.440490151650405
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20650.Liking for curry,34933,-0.284448506114458,0.0562009597571606,-0.394602387238493,-0.174294624990423,4.23155470397582e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20651.Liking for dairy products,34933,0.156373621767015,0.055818247749625,0.0469698561777503,0.26577738735628,0.00509573692915005
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20652.Liking for dark chocolate,34933,-0.104744025740388,0.0555979680577277,-0.213716043133534,0.00422799165275822,0.0595973684331182
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,34933,0.069726126130251,0.0564608613494944,-0.0409371621147581,0.18038941437526,0.216876752696088
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20654.Liking for dried fruit,34933,0.0102366879591411,0.0555255710508267,-0.0985934313004791,0.119066807218761,0.853734515387124
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20655.Liking for eggs,34933,-0.11641431310035,0.0563971850158588,-0.226952795731433,-0.00587583046926655,0.0390232858851272
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20656.Liking for exercising alone,34933,-0.107055152385669,0.0551084497465095,-0.215067713888827,0.00095740911749008,0.0520866017593204
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20657.Liking for exercising with others,34933,-0.0633327203039473,0.0546558815071924,-0.170458248058044,0.0437928074501498,0.246581489532245
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,34933,-0.283135940158991,0.0559115761505116,-0.392722629413993,-0.173549250903988,4.17172642748067e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20659.Liking for fatty foods,34933,0.107280724576405,0.0541369761496132,0.00117225132316275,0.213389197829647,0.0475427520838646
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20660.Liking for fresh tomatoes,34933,-0.181945119482925,0.0581312664505467,-0.295882401725997,-0.0680078372398535,0.00175319953009096
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20661.Liking for fried chicken,34933,-0.0772331341900687,0.0543172156083945,-0.183694876782522,0.0292286084023844,0.155086222386459
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20662.Liking for fried or battered fish,34933,-0.130979012847366,0.0548431267473198,-0.238471541272112,-0.0234864844226189,0.0169455608242237
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20663.Liking for fruit,34933,-0.0157584217835505,0.060057289334398,-0.133470708878971,0.10195386531187,0.793025799689824
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20664.Liking for garlic,34933,-0.318449694599005,0.055977072978819,-0.42816475763749,-0.208734631560519,1.31081821482737e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20665.Liking for gherkins,34933,-0.251532174568491,0.054772304215448,-0.35888589083077,-0.144178458306213,4.43173183172332e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20666.Liking for globe artichoke,34933,-0.277140552222391,0.0541534376551077,-0.383281290026402,-0.17099981441838,3.14488911305726e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20667.Liking for goat's cheese,34933,-0.316683944085082,0.0541429976358492,-0.422804219451346,-0.210563668718817,5.08450129019384e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20668.Liking for going to a cafe,34933,0.125378577879253,0.0548042562420573,0.0179622356448204,0.232794920113685,0.0221707137861655
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20669.Liking for going to the gym,34933,-0.104967031930561,0.0545821161299907,-0.211947979545343,0.00201391568422066,0.0544927498185929
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20670.Liking for going to the pub,34933,-0.445927210616595,0.0543393191445976,-0.552432276140006,-0.339422145093184,2.53287349829976e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20671.Liking for grapefruit,34933,-0.076460626042345,0.0548663090855684,-0.183998591850059,0.031077339765369,0.163472270249354
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20672.Liking for green olives,34933,-0.364475667223856,0.0554516806230915,-0.473160961245116,-0.255790373202597,5.1580696390236e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20673.Liking for haddock,34933,-0.296822777380755,0.0559699783107484,-0.406523934869822,-0.187121619891688,1.15952121815587e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20674.Liking for ham,34933,-0.169771086229786,0.054710660240941,-0.27700398030203,-0.0625381921575413,0.00192006068142439
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20675.Liking for hard cheese,34933,0.0610106663038202,0.0561183028902773,-0.0489812073611233,0.171002539968764,0.276981189416732
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20676.Liking for herring,34933,-0.224211277529421,0.0544205796841088,-0.330875613710274,-0.117546941348568,3.81677102090434e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20677.Liking for honey,34933,0.0663000732481995,0.0548840045331345,-0.0412725756367441,0.173872722133143,0.227071710238315
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,34933,-0.329938430028168,0.0546177023105643,-0.436989126556874,-0.222887733499462,1.58215032035133e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20679.Liking for ice cream,34933,0.214944755847266,0.0552063550730149,0.106740299904157,0.323149211790375,9.93975178346011e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20680.Liking for jam,34933,0.289278481483025,0.0548897590808888,0.181694553684483,0.396862409281567,1.38859972058723e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20681.Liking for kiwi fruit,34933,-0.0149393991051912,0.0551716457145785,-0.123075824705765,0.0931970264953826,0.786565003149014
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20682.Liking for lager,34933,-0.408363494713055,0.0552387050354068,-0.516631356582452,-0.300095632843658,1.54258085303613e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20683.Liking for lamb,34933,-0.274031773370725,0.0553947302952108,-0.382605444749339,-0.165458101992112,7.65166131262128e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20684.Liking for lemons,34933,-0.239368110048435,0.0549855908418646,-0.34713986809849,-0.13159635199838,1.35315929144847e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20685.Liking for lentils or beans,34933,-0.0837599126463229,0.0552131637751349,-0.191977713645587,0.0244578883529415,0.129288197594358
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20686.Liking for liver,34933,-0.172642630094395,0.0555658578118091,-0.281551711405541,-0.0637335487832492,0.00189480551524944
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20687.Liking for mackerel,34933,-0.330785028297245,0.0551207367465041,-0.438821672320393,-0.222748384274097,2.02125888897394e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20688.Liking for marzipan,34933,0.177290692672965,0.0546389296463535,0.0701983905661125,0.284382994779818,0.00117895221652974
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20689.Liking for mayonnaise,34933,-0.0837321571825481,0.0551876594746583,-0.191899969752878,0.0244356553877822,0.129238180038786
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20690.Liking for melon,34933,-0.088381493909655,0.0564547323481261,-0.199032769311982,0.0222697814926722,0.117487633145954
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20691.Liking for milk chocolate,34933,0.128945214163354,0.0551168070895236,0.0209162722678873,0.23697415605882,0.0193277851722954
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20692.Liking for mushrooms,34933,-0.234816971039226,0.056715799353026,-0.345979937771157,-0.123654004307295,3.49517870384468e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20694.Liking for orange juice,34933,0.0146043246132154,0.0553093262589427,-0.0938019548543123,0.123010604080743,0.791747743688099
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20695.Liking for oranges,34933,-0.122775614770241,0.0557059293067585,-0.231959236211488,-0.0135919933289945,0.0275451816329292
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20696.Liking for pasta,34933,-0.0130153063944061,0.0552086740354605,-0.121224307503909,0.0951936947150964,0.813632979160204
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20697.Liking for pears,34933,0.104487857888746,0.0555476218367613,-0.00438548091130592,0.213361196688798,0.0599913463139229
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20698.Liking for pizza,34933,0.110146797187237,0.0545489799787574,0.00323079642887288,0.217062797945602,0.0434876532630986
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20699.Liking for plain yogurt,34933,-0.163127024323952,0.0549344405579219,-0.270798527817479,-0.0554555208304249,0.0029893883569721
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20700.Liking for plums,34933,-0.0125595474816517,0.0559442500394973,-0.122210277559066,0.0970911825957631,0.822371531567166
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20701.Liking for pollock,34933,-0.273518490465502,0.0541021626197554,-0.379558729200222,-0.167478251730781,4.35922061826671e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20702.Liking for pork chop,34933,-0.192735450566707,0.0548710021466528,-0.300282614774146,-0.0851882863592673,0.000445650408665824
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20703.Liking for porridge,34933,0.157419351030177,0.0557982357432479,0.0480548089734112,0.266783893086943,0.0047925923429753
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20704.Liking for potato crisps,34933,0.0458329095970768,0.0551659580016317,-0.0622923680861214,0.153958187280275,0.406093984086416
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20705.Liking for potatoes,34933,0.207259665992748,0.0558346544707881,0.0978237432300032,0.316695588755492,0.000206615987080141
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20706.Liking for prawns,34933,-0.445096222966761,0.0561498658091169,-0.55514995995263,-0.335042485980891,2.46194600920766e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20707.Liking for raw carrots,34933,-0.0697000805313537,0.055545397790128,-0.178569060200005,0.0391688991372971,0.209566664367705
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20708.Liking for red meat,34933,-0.235076181692492,0.0548968362786806,-0.342673980798706,-0.127478382586278,1.86662451434985e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20709.Liking for red wine,34933,-0.665800616431248,0.0551609029031033,-0.77391598612133,-0.557685246741165,2.45878518020715e-33
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,34933,0.148299174909609,0.0563420663737166,0.0378687248171245,0.258729625002094,0.0084971268339297
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20711.Liking for roast chicken,34933,-0.215812313805321,0.0570737500002909,-0.327676863805891,-0.103947763804751,0.000156839516164055
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20712.Liking for salad dressing,34933,-0.0720878346592518,0.054553143405024,-0.179011995733099,0.0348363264145953,0.186387342169145
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20713.Liking for salad leaves,34933,-0.165543152235172,0.0560533960271585,-0.275407808448403,-0.0556784960219415,0.00315045463208891
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20714.Liking for salami,34933,-0.309199509038301,0.0548595242816943,-0.416724176630422,-0.20167484144618,1.78092317127774e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20715.Liking for salmon,34933,-0.33126469150923,0.0576944106820991,-0.444345736446144,-0.218183646572315,9.61908583793538e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20716.Liking for salty foods,34933,-0.0577973025739779,0.0543312651260889,-0.164286582221112,0.0486919770731564,0.287445006961073
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20717.Liking for salty pretzels,34933,-0.112622239737353,0.0547316980192804,-0.219896367855143,-0.00534811161956378,0.0396408697865041
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20718.Liking for sardines,34933,-0.397571433583381,0.0552047773893894,-0.505772797266584,-0.289370069900178,6.33009677140391e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20719.Liking for sausages (meat),34933,-0.13679986512629,0.0547037714473672,-0.24401925716313,-0.0295804730894506,0.0124077866760754
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20720.Liking for savoury biscuits,34933,0.0259153253181208,0.0549850622936325,-0.0818553967773988,0.13368604741364,0.637424570244217
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),34933,-0.482176447350378,0.0550711695078796,-0.590115939585822,-0.374236955114934,2.32681325079507e-18
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20722.Liking for skimmed milk,34933,-0.158037989156589,0.0542221127870189,-0.264313330219146,-0.0517626480940319,0.00356811799206814
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20723.Liking for smoked fish,34933,-0.309623931014359,0.0555190547678412,-0.418441278359328,-0.20080658366939,2.50597208472151e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20724.Liking for soft cheese,34933,-0.199909269859118,0.0548044118000684,-0.307325916987252,-0.0924926227309841,0.000265828870944207
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20725.Liking for soy sauce,34933,-0.238802769192051,0.0552670508266894,-0.347126188812362,-0.130479349571739,1.56759200352144e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20726.Liking for soya milk,34933,-0.0274004924132556,0.0547593410237349,-0.134728800819776,0.0799278159932648,0.616817314132437
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20727.Liking for spicy foods,34933,-0.291226104216318,0.0552117635547675,-0.399441160783662,-0.183011047648974,1.35475245447194e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20728.Liking for spinach,34933,-0.252902970280467,0.0556865239769625,-0.362048557275314,-0.143757383285621,5.64332423811369e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20729.Liking for spirits,34933,-0.457276900304163,0.0547558653601678,-0.564598396410092,-0.349955404198234,7.56274014842479e-17
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20730.Liking for strawberries,34933,-0.0183129262166627,0.0597731791985475,-0.135468357445816,0.0988425050124904,0.75932594459387
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,34933,0.06742169696083,0.0557802676030228,-0.0419076275410946,0.176751021462755,0.226803349539429
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20732.Liking for sweet foods,34933,0.418102284836777,0.0552292716541517,0.30985291239464,0.526351657278914,4.01968277007674e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20733.Liking for taking the stairs,34933,-0.198742673790551,0.056083858268696,-0.308667035997195,-0.0888183115839069,0.000396225938166018
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20734.Liking for tea with sugar,34933,0.203584102838806,0.0654033911123929,0.0753934562585162,0.331774749419097,0.0018582834493298
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20735.Liking for tea without sugar,34933,-0.180249116303721,0.0576580667157833,-0.293258927066657,-0.0672393055407862,0.00177555703768495
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20736.Liking for tomato ketchup,34933,0.0438336644051514,0.0545437751471236,-0.063072134883211,0.150739463693514,0.421621068481036
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20737.Liking for tinned tuna,34933,-0.156248240049852,0.0559284438686913,-0.265867990032487,-0.0466284900672171,0.0052195656509223
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20738.Liking for turnip (white),34933,-0.086701587497254,0.0547808550009521,-0.19407206329912,0.0206688883046122,0.113518739362656
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20739.Liking for vegetables,34933,-0.105671048737613,0.0607300985140986,-0.224702041825246,0.0133599443500204,0.0818848648862464
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20740.Liking for vinegar,34933,-0.100291922932558,0.0552383880937979,-0.208559163596402,0.00797531773128612,0.0694557390201642
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20741.Liking for watching television,34933,0.159078621291148,0.055135345828717,0.0510133434668631,0.267143899115434,0.003918729245221
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20742.Liking for whisky,34933,-0.357688886670398,0.0568154844890294,-0.469047236268895,-0.2463305370719,3.17764968806054e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20743.Liking for white bread,34933,0.105712232439331,0.0547330563294081,-0.00156455796630935,0.212989022844971,0.0534572923524666
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20744.Liking for white rice,34933,0.0133900781629497,0.055001145363217,-0.0944121667489556,0.121192323074855,0.807660633049683
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20745.Liking for white wine,34933,-0.443619627539205,0.0550568860657448,-0.551531124228065,-0.335708130850345,8.58847935156128e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,34933,-0.0760094274773808,0.055258263570206,-0.184315624074984,0.0322967691202229,0.168994880533612
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20747.Liking for whole milk,34933,0.150328335013761,0.0548096096839428,0.0429015000332334,0.257755169994289,0.00610275286843602
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20748.Liking for wholemeal bread,34933,-0.0819372820203631,0.0571077565883499,-0.193868484933529,0.0299939208928027,0.151376990548391
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20749.Liking for working up a sweat,34933,-0.0887886023903456,0.0545331523399571,-0.195673580976661,0.0180963761959704,0.103519805318397
EPHA2,Ephrin type-A receptor 2,Physical measures,X21001.Body mass index (BMI),51030,-0.109024902227949,0.00823334907720891,-0.125162266419278,-0.0928875380366194,6.68594665496248e-40
EPHA2,Ephrin type-A receptor 2,Physical measures,X21002.Weight,51050,0.00721062636052753,0.00480667531824592,-0.00221045726323447,0.0166317099842895,0.133592960944142
EPHA2,Ephrin type-A receptor 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32746,0.00177487018460915,0.00374076441402857,-0.00555702806688684,0.00910676843610514,0.635178409664022
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34322,0.0481161241978932,0.0585757874891364,-0.0666924192808142,0.162924667676601,0.411418017404879
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34322,-0.129963434650107,0.0607972420174534,-0.249126029004316,-0.0108008402958983,0.0325679957023012
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34322,0.0906046943826246,0.0597201575652586,-0.0264468144452823,0.207656203210531,0.129257952093436
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21040.Satisfaction with bowel habits,34292,0.0058201359627579,0.0557447984444824,-0.103439668988428,0.115079940913943,0.916848536276424
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34290,0.089058521836634,0.0590716471979804,-0.0267219066714075,0.204838950344676,0.131678113895876
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34282,0.0328923410829995,0.0606616885796972,-0.086004568533207,0.151789250699206,0.587674462022406
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21043.Least number of times bowels opened per week,34224,-0.0883950642350662,0.0594986455028896,-0.20501240942073,0.0282222809505974,0.137398131462748
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21044.Average number of times bowels opened per day,34253,0.122530540129392,0.0670440638577179,-0.0088758250317348,0.253936905290519,0.0676364723226684
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34327,-0.109522403015708,0.060823075448672,-0.228735630895106,0.00969082486368864,0.0717833872182745
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34322,-0.0144434814073642,0.0611657407212602,-0.134328333221034,0.105441370406306,0.813331153071244
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29987,-0.0395649632663109,0.0910311671942865,-0.217986050967112,0.138856124434491,0.663845630100634
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34325,-0.0154822159057983,0.0643775108985796,-0.141662137267014,0.110697705455418,0.809954303423495
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34322,0.133427086534304,0.0929007375645888,-0.0486583590922899,0.315512532160898,0.150966011154853
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34325,-0.160338740006116,0.0721708713034755,-0.301793647760928,-0.018883832251304,0.0263279753052809
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34323,-0.383210771525697,0.171262226429202,-0.718884735326932,-0.0475368077244617,0.0252702476039259
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34325,0.0647460102113816,0.0689410465284033,-0.0703784409842888,0.199870461407052,0.347675216948038
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34325,-0.179607276251742,0.0710318171867531,-0.318829637937778,-0.0403849145657062,0.0114681576848376
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34086,0.258535922080466,0.0635493841524346,0.133979129141694,0.383092715019238,4.77196731205373e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34325,-0.0412364268033338,0.0635914380012191,-0.165875645285723,0.0834027916790556,0.516702487344165
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34326,-0.22031569367954,0.0862581197213768,-0.389381608333439,-0.0512497790256419,0.0106589489343036
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34324,-0.143625110162605,0.0608616980101542,-0.262914038262507,-0.0243361820627025,0.0183000695456434
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34322,0.0908898209481708,0.0608068700511841,-0.0282916443521501,0.210071286248492,0.135015221693894
EPHA2,Ephrin type-A receptor 2,Working and living environment,X21100.Water hardness (USGS classification),50801,0.0598840401513032,0.0358720684550608,-0.0104252140206161,0.130193294323222,0.0950541196399725
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2139.Age first had sexual intercourse,48185,0.00534392584999278,0.00222457346228319,0.000983761863917733,0.00970408983606783,0.0163031322446313
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2149.Lifetime number of sexual partners,46240,-0.163984173254306,0.0401475094596114,-0.242673291795145,-0.085295054713468,4.43175572699787e-05
EPHA2,Ephrin type-A receptor 2,Physical activities,X22032.IPAQ activity group,46232,-0.0375301165592305,0.0393143512101796,-0.114586244931182,0.0395260118127215,0.339782136498948
EPHA2,Ephrin type-A receptor 2,Physical activities,X22033.Summed days activity,46792,-0.0048395766009945,0.00211924049979689,-0.0089932879805964,-0.000685865221392606,0.0224019586259278
EPHA2,Ephrin type-A receptor 2,Physical activities,X22034.Summed minutes activity,46232,-0.00381253929141164,0.00216393619129153,-0.00805385422634304,0.000428775643519763,0.0781076507996059
EPHA2,Ephrin type-A receptor 2,Physical activities,X22037.MET minutes per week for walking,45486,-0.00224119133380748,0.00212186153788914,-0.00640003994807019,0.00191765728045523,0.290871175067309
EPHA2,Ephrin type-A receptor 2,Physical activities,X22038.MET minutes per week for moderate activity,46232,-0.00132739065103498,0.00221610548512935,-0.00567095740188851,0.00301617609981855,0.549195961381614
EPHA2,Ephrin type-A receptor 2,Physical activities,X22039.MET minutes per week for vigorous activity,46232,-0.132929030684734,0.0392612166740004,-0.209881015365775,-0.0559770460036936,0.000711036389079299
EPHA2,Ephrin type-A receptor 2,Physical activities,X22040.Summed MET minutes per week for all activity,45486,-0.00164032030864894,0.002181487690525,-0.00591603618207794,0.00263539556478006,0.452102918917529
EPHA2,Ephrin type-A receptor 2,Eye measures,X2217.Age started wearing glasses or contact lenses,45625,-0.00396884001338182,0.00256183109452741,-0.00899002895865555,0.00105234893189191,0.121343378503394
EPHA2,Ephrin type-A receptor 2,Working and living environment,X22501.Year ended full time education,31111,-0.0213406182749245,0.0107191164863559,-0.0423500865881821,-0.000331149961666964,0.0465300760019697
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X22506.Tobacco smoking,31062,-0.214837495211581,0.136919328046062,-0.483199378181862,0.0535243877586994,0.116673045330681
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49191,-0.110216416294727,0.0796662121774076,-0.266362192162446,0.0459293595729921,0.166530677579563
EPHA2,Ephrin type-A receptor 2,Physical measures,X23098.Weight,50680,0.0095838361754485,0.00482504710754872,0.000126743844653008,0.019040928506244,0.0470137465642759
EPHA2,Ephrin type-A receptor 2,Physical measures,X23099.Body fat percentage,50658,-0.0354228285639288,0.0046558986852735,-0.0445483899870648,-0.0262972671407927,2.87144520192653e-14
EPHA2,Ephrin type-A receptor 2,Physical measures,X23100.Whole body fat mass,50621,-0.0225397872461564,0.00442400124876923,-0.0312108296937441,-0.0138687447985688,3.51318794819846e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23101.Whole body fat-free mass,50675,0.0244635614037085,0.00412030663770977,0.0163877603937973,0.0325393624136196,2.93289998148923e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23102.Whole body water mass,50680,0.024359241966033,0.00411973803014127,0.0162845554269561,0.0324339285051099,3.40382642613916e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23104.Body mass index (BMI),50680,-0.104275735778474,0.00827722761666872,-0.120499101907145,-0.0880523696498035,2.74759188178722e-36
EPHA2,Ephrin type-A receptor 2,Physical measures,X23105.Basal metabolic rate,50678,0.0242872136012324,0.00441868281516518,0.0156265952835086,0.0329478319189562,3.9096638045643e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23106.Impedance of whole body,50677,-0.0119574404969395,0.00338528705515465,-0.0185926031250426,-0.00532227786883635,0.00041284199887634
EPHA2,Ephrin type-A receptor 2,Physical measures,X23107.Impedance of leg (right),50677,-0.0291306509690939,0.00278116162986767,-0.0345817277636346,-0.0236795741745533,1.27089109424586e-25
EPHA2,Ephrin type-A receptor 2,Physical measures,X23108.Impedance of leg (left),50676,-0.026897034577425,0.00276391892944617,-0.0323143156791395,-0.0214797534757105,2.41015726192633e-22
EPHA2,Ephrin type-A receptor 2,Physical measures,X23109.Impedance of arm (right),50670,0.00739047766806268,0.00339731768928036,0.000731734997073164,0.0140492203390522,0.029609902265063
EPHA2,Ephrin type-A receptor 2,Physical measures,X23110.Impedance of arm (left),50675,0.00788224429780125,0.00339324410187151,0.00123148585813309,0.0145330027374694,0.0201907397729151
EPHA2,Ephrin type-A receptor 2,Physical measures,X23111.Leg fat percentage (right),50676,-0.0813617671610289,0.00573880565653276,-0.0926098262478331,-0.0701137080742247,1.84428656343299e-45
EPHA2,Ephrin type-A receptor 2,Physical measures,X23112.Leg fat mass (right),50675,-0.0578428019968383,0.00597024311499628,-0.069544478502231,-0.0461411254914456,3.66845011008841e-22
EPHA2,Ephrin type-A receptor 2,Physical measures,X23113.Leg fat-free mass (right),50675,0.0456637131767415,0.00442023454913378,0.0370000534604393,0.0543273728930437,5.70709039253021e-25
EPHA2,Ephrin type-A receptor 2,Physical measures,X23114.Leg predicted mass (right),50674,0.0463021310807972,0.00443685345605363,0.037605898306932,0.0549983638546623,1.90392186858595e-25
EPHA2,Ephrin type-A receptor 2,Physical measures,X23115.Leg fat percentage (left),50673,-0.080142058198598,0.00594277232933949,-0.0917898919641034,-0.0684942244330926,2.59174591810179e-41
EPHA2,Ephrin type-A receptor 2,Physical measures,X23116.Leg fat mass (left),50673,-0.055113842422079,0.00621168875592025,-0.0672887523836827,-0.0429389324604753,7.58087369855178e-19
EPHA2,Ephrin type-A receptor 2,Physical measures,X23117.Leg fat-free mass (left),50671,0.0433259375148537,0.00459006399404358,0.0343294120865283,0.0523224629431791,4.05598316144239e-21
EPHA2,Ephrin type-A receptor 2,Physical measures,X23118.Leg predicted mass (left),50670,0.042581764542965,0.00460789027057573,0.0335502996126366,0.0516132294732934,2.61631477906304e-20
EPHA2,Ephrin type-A receptor 2,Physical measures,X23119.Arm fat percentage (right),50670,-0.0350534608524808,0.00515474327599686,-0.0451567576734346,-0.0249501640315269,1.06641559192733e-11
EPHA2,Ephrin type-A receptor 2,Physical measures,X23120.Arm fat mass (right),50667,-0.0270798292018272,0.00503618708574602,-0.0369507558898894,-0.017208902513765,7.63489412311045e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23121.Arm fat-free mass (right),50667,0.0142069351674591,0.00412344655256505,0.00612497992443159,0.0222888904104866,0.000571081473060588
EPHA2,Ephrin type-A receptor 2,Physical measures,X23122.Arm predicted mass (right),50666,0.0139380260356709,0.00412532571488669,0.00585238763449302,0.0220236644368488,0.000729467386869467
EPHA2,Ephrin type-A receptor 2,Physical measures,X23123.Arm fat percentage (left),50662,-0.0321327415687825,0.00526179221403953,-0.0424458543082999,-0.021819628829265,1.03041769428683e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23124.Arm fat mass (left),50661,-0.0270927029490189,0.00501511550255887,-0.0369223293340343,-0.0172630765640035,6.63854159729472e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23125.Arm fat-free mass (left),50657,0.0124724701233538,0.004188265664635,0.00426346942066916,0.0206814708260383,0.00290437429479273
EPHA2,Ephrin type-A receptor 2,Physical measures,X23126.Arm predicted mass (left),50656,0.0124665546595783,0.00421019593106949,0.00421457063468214,0.0207185386844745,0.00306871730706205
EPHA2,Ephrin type-A receptor 2,Physical measures,X23127.Trunk fat percentage,50653,-0.014739529102668,0.00334928975604257,-0.0213041370245114,-0.00817492118082455,1.08272603241331e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X23128.Trunk fat mass,50649,-0.0116614614437772,0.00364896090452352,-0.0188134248166433,-0.00450949807091105,0.00139590532291533
EPHA2,Ephrin type-A receptor 2,Physical measures,X23129.Trunk fat-free mass,50644,0.0134676618838088,0.00375531870860303,0.00610723721494686,0.0208280865526707,0.00033601282119603
EPHA2,Ephrin type-A receptor 2,Physical measures,X23130.Trunk predicted mass,50643,0.0137723768332457,0.00374862573783279,0.00642507038709341,0.0211196832793979,0.000239266453203931
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23400.Total Cholesterol,39248,-0.0240533646302986,0.00285183071939652,-0.0296429528403158,-0.0184637764202814,3.62297909867134e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39248,-0.0157701336460005,0.00277435955080495,-0.0212078783655782,-0.0103323889264228,1.33776278021078e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39248,-0.00905805546465021,0.00278698504154728,-0.0145205461460829,-0.00359556478321755,0.001156012945663
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23403.VLDL Cholesterol,39248,0.00246225299850724,0.00274643417556709,-0.00292075798560425,0.00784526398261873,0.369985273651794
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39248,-0.0219555924781192,0.00277071794402369,-0.0273861996484056,-0.0165249853078328,2.45355876792048e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23405.LDL Cholesterol,39248,-0.0208858335263655,0.0027477062171737,-0.026271337712026,-0.0155003293407051,3.10310801978785e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23406.HDL Cholesterol,39248,-0.0356367558803018,0.00311711732871248,-0.0417463058445783,-0.0295272059160253,3.80307560644459e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23407.Total Triglycerides,39248,0.0143185882323758,0.0028122559051784,0.00880656665822616,0.0198306098065255,3.59443725921465e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23408.Triglycerides in VLDL,39248,0.012473581640676,0.00285680030463192,0.00687425304359745,0.0180729102377546,1.27207281757953e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23409.Triglycerides in LDL,39248,0.0140527997630839,0.00269145119729523,0.00877755541638528,0.0193280441097826,1.80010982927303e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23410.Triglycerides in HDL,39248,0.0204938146850857,0.0026554540598027,0.0152891247278725,0.025698504642299,1.25765160095416e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39248,-0.0199237217478818,0.00282569058753268,-0.0254620752994458,-0.0143853681963177,1.85299449947045e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23412.Phospholipids in VLDL,39248,0.00852787738273805,0.00277341620165772,0.00309198162748892,0.0139637731379872,0.00210967575469175
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23413.Phospholipids in LDL,39248,-0.0201598590941425,0.00275112938277443,-0.0255520726843804,-0.0147676455039046,2.45490791013771e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23414.Phospholipids in HDL,39248,-0.0246391868117125,0.0029388395121457,-0.030399312255518,-0.0188790613679069,5.55538288244717e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23415.Total Esterified Cholesterol,39248,-0.0262939542737156,0.00286070082700367,-0.0319009278946428,-0.0206869806527884,4.3628353979809e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39248,0.000476286370623176,0.00274696116209846,-0.00490775750708981,0.00586033024833616,0.862349805086624
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39248,-0.0194053369655458,0.002737852997768,-0.024771528841171,-0.0140391450899205,1.42187200361428e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39248,-0.0377162224007494,0.00310928865732074,-0.0438104281690981,-0.0316220166324008,1.04164043105812e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23419.Total Free Cholesterol,39248,-0.0180377463994363,0.00282690027250305,-0.0235784709335423,-0.0124970218653303,1.81260282398919e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39248,0.00507000212746703,0.00276099560571468,-0.00034154925973375,0.0104815535146678,0.066333334812961
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23421.Free Cholesterol in LDL,39248,-0.0242457258836051,0.00277993667017814,-0.0296944017571543,-0.018797050010056,3.0175997167344e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23422.Free Cholesterol in HDL,39248,-0.0259237187276387,0.0030993703467573,-0.031998484607283,-0.0198489528479944,6.56716265208831e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39248,-0.0139959300181336,0.00275763722312688,-0.0194008989754623,-0.00859096106080487,3.91325888724151e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23424.Total Lipids in VLDL,39248,0.00923747096321854,0.00279854530040807,0.00375232217441872,0.0147226197520184,0.000966249024891653
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23425.Total Lipids in LDL,39248,-0.0189786250126544,0.00274562331617984,-0.0243600467123669,-0.013597203312942,4.95532082658965e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23426.Total Lipids in HDL,39248,-0.0272538994565168,0.00300023922649323,-0.0331343683404435,-0.0213734305725901,1.17261812183247e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39248,-0.035752848216311,0.00282251696524518,-0.0412849814681916,-0.0302207149644305,1.37180345185631e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23428.Concentration of VLDL Particles,39248,0.00739198434693572,0.0027390234314882,0.00202349842121884,0.0127604702726526,0.00696729801634564
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23429.Concentration of LDL Particles,39248,-0.0112247324196265,0.00275376730147124,-0.0166221163305101,-0.00582734850874287,4.60200758325288e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23430.Concentration of HDL Particles,39248,-0.0359171115295952,0.00282246143275608,-0.0414491359377971,-0.0303850871213932,6.55243359520022e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39248,0.00814063603191563,0.00300151281745504,0.00225767090970375,0.0140236011541275,0.00669170236924939
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39248,-0.0179460327603795,0.00274793144796623,-0.0233319783983934,-0.0125600871223657,6.74961428809756e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39248,-0.00329653465532138,0.00318332358493229,-0.00953584888178866,0.0029427795711459,0.300421962657752
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23434.Phosphoglycerides,39237,-0.018613779287762,0.00279611804614731,-0.0240941706582107,-0.0131333879173133,2.88919197092625e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39237,0.0277658313270782,0.00300016229091905,0.0218855132368769,0.0336461494172796,2.42435638168789e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23436.Total Cholines,39237,-0.0207628133541533,0.00284106284895896,-0.0263312965381129,-0.0151943301701937,2.84234096372595e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23437.Phosphatidylcholines,39237,-0.0169036992178234,0.00283646663675883,-0.0224631738258707,-0.011344224609776,2.58663990139672e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23438.Sphingomyelins,39236,-0.0283959846062159,0.00292575883246427,-0.0341304719178459,-0.0226614972945859,3.30781220269433e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23439.Apolipoprotein B,39248,-0.0092143133854436,0.00276296492498625,-0.0146297246384167,-0.00379890213247055,0.000855204381512172
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23440.Apolipoprotein A1,39248,-0.02857172273642,0.00291565011165748,-0.0342863969552686,-0.0228570485175713,1.31841901567452e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39248,0.0070197912811414,0.00276329929988614,0.00160372465336456,0.0124358579089182,0.0110833980247652
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23442.Total Fatty Acids,39237,-0.00367941991775213,0.00269154118298655,-0.00895484063640577,0.00159600080090152,0.171635609648162
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23443.Degree of Unsaturation,39237,-0.0525400761220502,0.00294361105158498,-0.0583095537831568,-0.0467705984609437,1.51779016436829e-70
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39237,-0.0374396376524851,0.00271944652915809,-0.0427697528496349,-0.0321095224553352,7.19220834237201e-43
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39237,-0.00997553489297597,0.00272608203300822,-0.0153186556776721,-0.00463241410827987,0.000253757115050092
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39237,-0.0178062132765071,0.00272643721211464,-0.0231500302122518,-0.0124623963407624,6.74063894842186e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39237,0.0115048524987235,0.00273571971003674,0.00614284186705152,0.0168668631303955,2.62072077721051e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23448.Saturated Fatty Acids,39237,-0.00420397692953527,0.00270572966787171,-0.00950720707856382,0.00109925321949328,0.120269098708411
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23449.Linoleic Acid,39237,0.000942930027462658,0.00274550035586072,-0.00443825067002436,0.00632411072494968,0.731267952025533
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23450.Docosahexaenoic Acid,39237,-0.0499335189825012,0.00282336262375958,-0.0554673097250699,-0.0443997282399324,2.61626084618022e-69
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39237,-0.0442886788693404,0.00274114971280512,-0.0496613323064384,-0.0389160254322424,3.05893440908596e-58
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39237,-0.00650163209175801,0.00281874695027811,-0.0120263761143031,-0.000976888069212905,0.0210921311179922
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39237,-0.0265405782503779,0.00291998894721324,-0.0322637565869159,-0.02081739991384,1.11656693647416e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39237,0.0418035727795827,0.00296467982001186,0.0359928003323594,0.0476143452268059,7.17377878034818e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39237,-0.0033201189043933,0.00269714300469154,-0.00860651919358872,0.00196628138480213,0.218350585556743
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39237,0.0102322750592641,0.00288334325118751,0.00458092228693654,0.0158836278315916,0.000388212802790429
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39237,-0.0493534090475623,0.00285652112614993,-0.0549521904548162,-0.0437546276403085,2.93514891678521e-66
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39237,-0.0370153916144053,0.00296957679926259,-0.04283576214096,-0.0311950210878506,1.72254346451077e-35
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39235,0.0384106428198621,0.00272763905000377,0.0330644702818547,0.0437568153578694,9.29527561791667e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23460.Alanine,39245,0.00794317017197281,0.002663753337663,0.00272221363015332,0.0131641267137923,0.00286870578704925
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23461.Glutamine,39208,0.0132673706842807,0.00263863565019944,0.00809564480988979,0.0184390965586716,5.00901829241303e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23462.Glycine,39232,0.0445205660698308,0.002749445085366,0.0391316537025134,0.0499094784371481,1.73361929671096e-58
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23463.Histidine,39232,-0.00347242842391805,0.00262778547423007,-0.00862288795340899,0.00167803110557289,0.186378473541079
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39236,-0.0189636337766263,0.00280551018373832,-0.0244624337367534,-0.0134648338164992,1.43525325738138e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23465.Isoleucine,39246,-0.0104394746115856,0.00273400492126668,-0.0157981242572683,-0.00508082496590288,0.000134856874612339
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23466.Leucine,39247,-0.0181796767489402,0.00282132957541829,-0.0237094827167601,-0.0126498707811204,1.20096440814997e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23467.Valine,39236,-0.0207281645371092,0.0027938871984612,-0.0262041834460931,-0.0152521456281252,1.24066266875134e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23468.Phenylalanine,39245,0.011136249726163,0.00266165555783416,0.00591940483280802,0.0163530946195179,2.88069169931662e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23469.Tyrosine,39233,-0.00261624226434289,0.00271075233635615,-0.00792931684360094,0.00269683231491516,0.33449232331891
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23470.Glucose,39222,-0.00158393422421019,0.00271444736807232,-0.00690425106563194,0.00373638261721156,0.559551889795065
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23471.Lactate,39222,0.00665865233499362,0.0026631581219017,0.00143886241606629,0.0118784422539209,0.0124197069533527
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23472.Pyruvate,39205,-0.00211169963463847,0.00262663012728329,-0.00725989468411372,0.00303649541483677,0.421433832737548
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23473.Citrate,39248,0.0325045589818894,0.00269006132402739,0.0272320387867957,0.0377770791769831,1.83660126124211e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23474.3-Hydroxybutyrate,38997,-0.00991131947454535,0.00261441136219269,-0.015035565744443,-0.00478707320464767,0.000150604285212341
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23475.Acetate,39236,-0.00597673534677919,0.00266841413330564,-0.0112068270480582,-0.000746643645500145,0.0251176219046697
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23476.Acetoacetate,39248,-0.0177089062081723,0.00260603744270505,-0.0228167395958742,-0.0126010728204704,1.12025988141931e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23477.Acetone,39248,-0.0200997153242395,0.00261952396546162,-0.0252339822965443,-0.0149654483519347,1.7800755035145e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23478.Creatinine,38844,0.101520107822305,0.00316456124547222,0.0953175677811794,0.10772264786343,1.87792946732082e-218
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23479.Albumin,39248,-0.046087775240413,0.00267565622307512,-0.0513320614376403,-0.0408434890431858,7.16327541992012e-66
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23480.Glycoprotein Acetyls,39248,0.0192854728668059,0.00282904621849957,0.0137405422785467,0.024830403455065,9.64498884416227e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39248,0.0163306240643657,0.00283645848365521,0.0107711654364015,0.0218900826923299,8.70484622411301e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39248,0.0141682815778476,0.00285042281317057,0.00858145286403332,0.0197551102916619,6.74674775713556e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39248,0.0161368896591095,0.00285307011779126,0.0105448722282387,0.0217289070899804,1.5772116814124e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39248,0.0140270338180713,0.00283246986515085,0.00847539288237564,0.019578674753767,7.41467153214324e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39248,0.0136059016345356,0.00284427563870609,0.00803112138267164,0.0191806818863995,1.73772207618933e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39248,0.0142374239643951,0.0028097019447584,0.00873040815266858,0.0197444397761215,4.08309904583803e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39248,0.0128383762073476,0.00284793649586289,0.00725642067545637,0.0184203317392389,6.59377107827227e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39248,0.0144215558580348,0.00289068226050593,0.00875581862744316,0.0200872930886264,6.13611008444685e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39248,0.0130206573016927,0.00289441608194156,0.00734760178108719,0.0186937128222981,6.8921351629143e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39248,0.0140289991807395,0.00287560381898753,0.00839281569552396,0.0196651826659551,1.07895454468267e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39248,0.00989692401120696,0.00283516808719542,0.00433999456030395,0.01545385346211,0.000482977082940721
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39248,0.00659386116738897,0.00281125651498228,0.00108379839802369,0.0121039239367542,0.0190131375801353
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39248,0.0132122551785699,0.00285286682238314,0.00762063620669899,0.0188038741504409,3.66491875618146e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39248,0.0132656225219644,0.00292028377686965,0.00754186631929988,0.0189893787246289,5.59921738366761e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39248,0.0121224771330832,0.00286226643750472,0.00651243491557392,0.0177325193505924,2.29601757123086e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39248,0.00960778937869229,0.00286582434853322,0.00399077365556718,0.0152248051018174,0.000802667943778447
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39248,0.0133962758956209,0.00287909883141793,0.00775324218604173,0.0190393096052,3.29961529676689e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39248,0.00974411849113017,0.00281629107103605,0.00422418799189952,0.0152640489903608,0.000541816831824363
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39248,0.00861844867283024,0.00277130832559211,0.0031866843546697,0.0140502129909908,0.00187502342528746
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39248,0.0105755700650923,0.0028670361327782,0.00495617924484707,0.0161949608853376,0.000226199533214852
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39248,0.00702615775545748,0.00288264304816165,0.00137617738106066,0.0126761381298543,0.0148045015424281
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39248,-0.00224506817558948,0.00274298135930389,-0.00762131163982511,0.00313117528864615,0.413097331624944
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39248,-1.59933703113478e-05,0.00275247360618025,-0.00541084163842464,0.00537885489780195,0.995363957680895
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39248,-0.00203678462368494,0.00274208475528764,-0.00741127074404872,0.00333770149667884,0.457622049095903
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39248,-0.0102827313950108,0.0027693694875717,-0.0157106955906513,-0.00485476719937024,0.000205521551698698
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39248,-0.0140639992805685,0.00280136763368899,-0.019554679842599,-0.00857331871853813,5.21390685595175e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39248,-0.00457587627943416,0.00274116162852468,-0.00994855307134253,0.000796800512474204,0.0950742947199938
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39248,0.0064817886776796,0.00282063942115313,0.000953335412219458,0.0120102419431397,0.0215759581025761
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39248,0.0103727911938578,0.00275000093441803,0.00498278936239845,0.0157627930253171,0.000162601120974831
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39248,0.00773779873721729,0.00274467895528294,0.00235822798486272,0.0131173694895719,0.0048205011765946
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39248,0.000157973956089971,0.00272906369802374,-0.00519099089203656,0.0055069388042165,0.953840368873747
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39248,0.000934297851475179,0.00273479806733773,-0.00442590636050677,0.00629450206345713,0.732631603896482
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39248,0.00443758487194763,0.00273880997772185,-0.000930482684387203,0.00980565242828246,0.105196879587388
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39248,-0.00530171753206186,0.00273579463908565,-0.0106638750246697,6.04399605460123e-05,0.0526527529495394
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39248,0.0161960780043672,0.00277512639528473,0.0107568302696091,0.0216353257391252,5.44923801114886e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39248,0.00795071551597757,0.00274822430383401,0.00256419588046291,0.0133372351514922,0.00382071096964144
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39248,0.00835094113615968,0.00273954694926283,0.00298142911560453,0.0137204531567148,0.00230536169691122
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39248,0.0119837536593011,0.00272118001641639,0.00665024082712502,0.0173172664914773,1.07048547360028e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39248,-0.00109229592228684,0.0028420954792186,-0.0066628030615553,0.00447821121698162,0.700740915791654
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39248,-0.00443599669856711,0.00287962105306302,-0.0100800539625706,0.0012080605654364,0.123464120553396
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39248,0.00621105131082225,0.0027594777654009,0.000802474890636493,0.011619627731008,0.0244118336644572
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39248,0.0209699099807096,0.00269531699285039,0.0156870886747229,0.0262527312866964,7.70331298516211e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23523.Concentration of IDL Particles,39248,-0.0097154391106799,0.00282298776908318,-0.0152484951380829,-0.00418238308327688,0.000579939167710023
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23524.Total Lipids in IDL,39248,-0.0172217138924106,0.00288526069079338,-0.0228768248463656,-0.0115666029384556,2.44167873513539e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23525.Phospholipids in IDL,39248,-0.0137647972416174,0.00288564297128498,-0.019420657465336,-0.00810893701789887,1.85825968071175e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23526.Cholesterol in IDL,39248,-0.0217228585613572,0.00290097623597363,-0.0274087719838655,-0.0160369451388489,7.36522574265133e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39248,-0.0221769073030568,0.00289622034526813,-0.0278534991797823,-0.0165003154263312,2.01314020494928e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23528.Free Cholesterol in IDL,39248,-0.019717889644735,0.00290290528538288,-0.0254075840040855,-0.0140281952853846,1.14272049959946e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23529.Triglycerides in IDL,39248,0.0173729592795867,0.00266341668966576,0.0121526625678418,0.0225932559913316,7.11554118037817e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39248,-0.012296085905202,0.00275683954505238,-0.0176994914135047,-0.00689268039689936,8.24590087048662e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23531.Total Lipids in Large LDL,39248,-0.0206911670951565,0.00276541982955816,-0.0261113899610905,-0.0152709442292225,7.70900675835658e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23532.Phospholipids in Large LDL,39248,-0.022207264868169,0.00277511257605685,-0.0276464855172405,-0.0167680442190976,1.30781556609007e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23533.Cholesterol in Large LDL,39248,-0.0224906492802402,0.00276895781274825,-0.0279178065932268,-0.0170634919672536,4.91391188924159e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39248,-0.0216177186880349,0.00275329298043691,-0.0270141729296912,-0.0162212644463786,4.3776614423781e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39248,-0.0243614565941012,0.00281578691562929,-0.0298803989487346,-0.0188425142394678,5.56713690719556e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23536.Triglycerides in Large LDL,39248,0.0134015827405071,0.00267619442929305,0.00815624165909276,0.0186469238219215,5.56935722191733e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39248,-0.0108689414960397,0.00274355926286926,-0.0162463176512635,-0.00549156534081595,7.47783009466174e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39248,-0.0165749737106791,0.00272814115316892,-0.0219221303708902,-0.0112278170504681,1.26469914273118e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39248,-0.0178398316592375,0.00272219453913417,-0.0231753329559404,-0.0125043303625345,5.80004599864993e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39248,-0.0181426475835866,0.00272868495633771,-0.0234908700980086,-0.0127944250691647,3.05312768431504e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39248,-0.0156598322429113,0.00273361704974839,-0.0210177216604182,-0.0103019428254045,1.03148650829388e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39248,-0.0237701483324662,0.00272626501940826,-0.0291136277705064,-0.018426668894426,3.09115341617716e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39248,0.0139476554595809,0.00271332469490847,0.00862953905756025,0.0192657718616015,2.77468562244465e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39248,-0.00468627593412797,0.00275459623557914,-0.0100852845558631,0.000712732687607139,0.0889149545559468
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23545.Total Lipids in Small LDL,39248,-0.0137806621742057,0.0027473550804096,-0.0191654781318085,-0.00839584621660286,5.33531855643086e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23546.Phospholipids in Small LDL,39248,-0.0138825964101043,0.00275057984991736,-0.0192737329159424,-0.00849145990426631,4.53559845650725e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23547.Cholesterol in Small LDL,39248,-0.0163582192598499,0.00274353418228197,-0.0217355462571226,-0.0109808922625773,2.53900903634308e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39248,-0.013185179545258,0.00274592804424861,-0.0185671985119852,-0.00780316057853071,1.58788052442069e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39248,-0.0227847502642672,0.00273259222204858,-0.0281406310194824,-0.017428869509052,8.17938760462248e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23550.Triglycerides in Small LDL,39248,0.0166254594289204,0.00274418243105323,0.0112468618640561,0.0220040569937847,1.40651929352576e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39248,-0.000287123668032591,0.00320311164656513,-0.00656522249530024,0.00599097515923505,0.928575272327855
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39248,-0.00161096408661682,0.00321100516401381,-0.0079045342080839,0.00468260603485025,0.615885129605375
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39248,0.00134755376030061,0.00317517096144775,-0.00487578132413697,0.00757088884473819,0.671277480863913
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39248,-0.00842435711323272,0.00325735324467809,-0.0148087694728018,-0.00203994475366366,0.00971151334782781
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39248,-0.0121588664884734,0.00329539991524182,-0.0186178503223474,-0.00569988265459947,0.000225338453188328
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39248,0.00432853398173668,0.00306796300616914,-0.00168467351035483,0.0103417414738282,0.158299606953518
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39248,0.0244879598085459,0.00260907503439376,0.0193741727411341,0.0296017468759576,7.10744517780195e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39248,-0.0182330113218572,0.00327666362000671,-0.0246552720170704,-0.011810750626644,2.67284012491357e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23559.Total Lipids in Large HDL,39248,-0.0181981221246514,0.00322792249852906,-0.0245248502217683,-0.0118713940275344,1.75342779535474e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23560.Phospholipids in Large HDL,39248,-0.0176212953331573,0.00316195957390777,-0.0238187360980165,-0.0114238545682981,2.54733343078312e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23561.Cholesterol in Large HDL,39248,-0.022125778162607,0.00330118511724684,-0.0285961009924108,-0.0156554553328032,2.12186906458561e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39248,-0.023476119750034,0.00330698356310575,-0.0299578075337213,-0.0169944319663467,1.31201748327384e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39248,-0.0167779529486915,0.00326015944870321,-0.0231678654681498,-0.0103880404292332,2.68858286593484e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23564.Triglycerides in Large HDL,39248,0.0236108399865647,0.00263571373280528,0.0184448410702663,0.028776838902863,3.67753718034309e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39248,-0.0293448094871943,0.00288227832200641,-0.0349940749983269,-0.0236955439760618,2.8744198163917e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39248,-0.0283310438478947,0.0028369319712223,-0.0338914305114904,-0.0227706571842989,2.05768564805512e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39248,-0.025692915464365,0.00279231648179177,-0.0311658557686769,-0.0202199751600531,3.98272998717244e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39248,-0.0355254225198829,0.00292071182204575,-0.0412500176910926,-0.0298008273486733,6.9761768801917e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39248,-0.0365934882091404,0.00291374072194571,-0.042304420024154,-0.0308825563941268,5.33162659391782e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39248,-0.0299723760903657,0.00293382780127692,-0.0357226785808684,-0.0242220735998629,2.00926818814001e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39248,0.0166204077678493,0.00266586316475649,0.0113953159649265,0.021845499570772,4.64952987198978e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39248,-0.0358420908152194,0.00262780260015265,-0.0409925839115186,-0.0306915977189202,4.09347493221651e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23573.Total Lipids in Small HDL,39248,-0.029773391319549,0.00264501353863226,-0.0349576178552682,-0.0245891647838298,2.80235041502413e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23574.Phospholipids in Small HDL,39248,-0.0276631410452154,0.00265099385528449,-0.032859089001573,-0.0224671930888578,2.08597186201446e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23575.Cholesterol in Small HDL,39248,-0.0386427652721549,0.0026221891410902,-0.0437822559886916,-0.0335032745556181,8.04424152570322e-49
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39248,-0.0409379372047196,0.00261080098731761,-0.0460551071398622,-0.0358207672695771,5.50132593374453e-55
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39248,-0.0258302356702535,0.00267550354817316,-0.0310742226246729,-0.0205862487158341,5.43902849917273e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23578.Triglycerides in Small HDL,39248,0.0188948259186997,0.00286427870915446,0.0132808396487569,0.0245088121886424,4.34087642000671e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38502,0.0120094129062319,0.0026826259705559,0.00675146600394229,0.0172673598085214,7.63646247254513e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38502,-0.00556412775849782,0.00267962970234983,-0.0108162019751035,-0.000312053541892164,0.0378693847738514
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38502,-0.00463672625744961,0.00265709985404618,-0.00984464197138012,0.000571189456480901,0.0810001473454249
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38502,-0.00521218226630325,0.00272092086157743,-0.010545187154995,0.00012082262238851,0.0554361280475338
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38502,0.000330519603485068,0.00262838548607301,-0.00482111594921803,0.00548215515618817,0.89993150945229
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39061,0.0127556906108021,0.00261515079053551,0.00762999506135252,0.0178813861602517,1.08464569334622e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39061,-0.0146053229308291,0.0029115810154313,-0.0203120217210744,-0.00889862414058376,5.32741226680017e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39061,-0.0168915132867238,0.00289687526458918,-0.0225693888053186,-0.011213637768129,5.62334627003395e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39061,-0.00182198243247621,0.00278973680019305,-0.00728986656085459,0.00364590169590216,0.51370045851515
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39061,0.0084936012500607,0.00283070340034413,0.00294542258538619,0.0140417799147352,0.00269950124526151
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39244,0.0300110510075053,0.00282175170228926,0.0244804176710184,0.0355416843439923,2.51186203234707e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39244,0.000909036535956789,0.00273452998822325,-0.00445064224096078,0.00626871531287436,0.739570020217716
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39244,-0.002138462688806,0.00284968131650688,-0.00772383806915949,0.00344691269154749,0.453012244426712
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39244,0.00860600665308618,0.00266882954873069,0.00337510073757403,0.0138369125685983,0.00126395757496274
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39244,-0.0117788458884966,0.00262830487230739,-0.0169303234382191,-0.00662736833877412,7.46421002010857e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39248,-0.00948286692790442,0.00287447620569715,-0.0151168402910708,-0.00384889356473802,0.000972538338516278
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39248,-0.0198998101607927,0.00298578815829169,-0.0257519549510444,-0.014047665370541,2.73952796508018e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39248,-0.0215587145181388,0.0029936574143154,-0.027426283050197,-0.0156911459860806,6.23281412668074e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39248,-0.0146496939329718,0.00293612285538365,-0.0204044947295238,-0.00889489313641986,6.12062266308098e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39248,0.0177381156064185,0.0029699821421761,0.0119169506077534,0.0235592806050837,2.38841385157763e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39248,-0.0295788131377513,0.00284270927765183,-0.0351505233219489,-0.0240071029535538,2.84903554933965e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39248,-0.0168138756692101,0.00276162616582781,-0.0222266629542327,-0.0114010883841876,1.16756239233576e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39248,-0.00644950466976199,0.00269023704650967,-0.0117223692809209,-0.00117664005860303,0.016524900355453
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39248,-0.029352104897197,0.00286438998153737,-0.0349663092610102,-0.0237379005333837,1.46029134906589e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39248,0.0209545005461764,0.00278726606353054,0.0154914590616566,0.0264175420306963,5.87092332236254e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39248,0.0329384109155037,0.00276776379869988,0.0275135938700519,0.0383632279609554,1.62930660377385e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39248,-0.0288986613578729,0.0029198029430574,-0.0346214751262654,-0.0231758475894804,5.0021867669281e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39248,-0.0305121785795695,0.00294981099994918,-0.0362938081394699,-0.0247305490196691,5.39276174897889e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39248,-0.0125182357305366,0.0026788956871383,-0.0177688712773277,-0.00726760018374551,2.994792819161e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39248,0.0239764135035371,0.00289709167240851,0.0182981138256164,0.0296547131814578,1.37709588155409e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39248,0.0235882469173409,0.00268145986603362,0.0183325855799151,0.0288439082547668,1.55503349669534e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39248,-0.0352224043324588,0.0027930894172581,-0.0406968595902846,-0.0297479490746329,2.79180693222683e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39248,-0.0333620044574895,0.00275829483498107,-0.0387682623340524,-0.0279557465809266,1.59014416589304e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39248,-0.0170198074089242,0.002759577531791,-0.0224285793712345,-0.0116110354466138,7.10939657762298e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39248,0.0338969457256001,0.00282656434295575,0.0283568796134068,0.0394370118377934,5.47190298187564e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39248,-0.005474576977828,0.00268658350113752,-0.0107402806400575,-0.00020887331559846,0.0415923278162903
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39248,-0.034579688226971,0.00279999586394655,-0.0400676801203063,-0.0290916963336358,7.13387111601245e-35
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39248,-0.0231871327891935,0.00264141513518024,-0.0283643064541468,-0.0180099591242403,1.83169279316166e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39248,-0.0227879510409366,0.0029741967003561,-0.0286173765736346,-0.0169585255082387,1.94114706608484e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39248,0.0350396897779618,0.00274099974863562,0.029667330270636,0.0404120492852876,3.13387048992839e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39248,-0.00583537612498367,0.00265524421325553,-0.0110396547829645,-0.00063109746700283,0.0279867886270062
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39248,-0.0289280429909259,0.00276709132399422,-0.0343515419859546,-0.0235045439958973,1.70437289782615e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39248,-0.00256196447174668,0.00275155613332397,-0.00795501449306167,0.0028310855495683,0.351818220939523
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39248,-0.0246057023782266,0.00287602691115133,-0.0302427151240833,-0.01896868963237,1.28355241250258e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39248,0.0339046048852224,0.00268277981234212,0.0286463564530319,0.039162853317413,1.98049274584461e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39248,0.00310239777381047,0.00271983289578665,-0.00222847470193136,0.0084332702495523,0.254030233862164
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39248,-0.0276152794663405,0.00267806431262519,-0.0328642855190859,-0.0223662734135951,7.51955920679092e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39248,-0.00369898674019123,0.00272630045379682,-0.00904253562963301,0.00164456214925054,0.174871398741106
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39248,-0.02689036451814,0.00273546167287516,-0.0322518693969753,-0.0215288596393047,9.7285099072301e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39248,0.0309274369699798,0.00275100791778863,0.0255354614511141,0.0363194124888455,3.28760656284964e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39244,0.00939604044950308,0.0030205293226069,0.00347580297719355,0.0153162779218126,0.00186968992965013
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39244,-0.022319914981093,0.00277528542772464,-0.0277594744194333,-0.0168803555427527,9.44831695046907e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39244,-0.0374692404358066,0.00262880118120403,-0.0426216907509665,-0.0323167901206467,8.36114589231462e-46
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39244,0.0116783872262094,0.00318009019452965,0.00544541044493125,0.0179113640074875,0.000241149431171415
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39244,0.0236975606878967,0.0029416986623033,0.0179318313097822,0.0294632900660112,8.47556852130953e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39248,0.00203626745695324,0.00297883986041562,-0.00380225866946138,0.00787479358336787,0.494252384071641
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39248,-0.0234739004817041,0.00302681095655272,-0.0294064499565475,-0.0175413510068608,9.36187572493625e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39248,-0.0253741901070316,0.00292374707051362,-0.0311047343652383,-0.0196436458488249,4.40078652971721e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39248,-0.00106297716398972,0.00297912831818532,-0.00690206866763295,0.0047761143396535,0.721240352086806
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39248,0.0370712788458612,0.00284887431245008,0.0314874851934591,0.0426550724982634,1.65637172321347e-38
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39248,0.0270964163836796,0.00299052249601799,0.0212349922914843,0.0329578404758748,1.44858145895313e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39248,-0.0352841759672008,0.0029203654640894,-0.0410080922768161,-0.0295602596575856,1.86097270702876e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39248,-0.0319970493381061,0.00279583659407326,-0.0374768890624897,-0.0265172096137225,3.31820978206247e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39248,-0.0265400071992404,0.00315620617324969,-0.0327261712988098,-0.020353843099671,4.5006776620878e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39248,0.0371470471585548,0.00283621670945546,0.0315880624080221,0.0427060319090875,5.50735983877501e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39248,0.0104280085434916,0.00267419637128004,0.00518658365578273,0.0156694334312005,9.68038767089587e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39248,-0.0296245192889941,0.00265206737545222,-0.0348225713448805,-0.0244264672331078,7.35447111101475e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39248,-0.0310250688410155,0.0026033240001784,-0.0361275838813651,-0.0259225538006658,1.33522127203747e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39248,0.00779079476183908,0.00289625102452955,0.00211414275376115,0.013467446769917,0.00715380189492181
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39248,0.0389683662140849,0.00290113538366606,0.0332821408620995,0.0446545915660704,6.66503592493901e-41
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,50706,-0.00355056648359819,0.00225708131739577,-0.0079744458656939,0.000873312898497513,0.11571238681872
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,50706,-0.00126177493784534,0.00220577295516043,-0.00558508992995979,0.0030615400542691,0.567304402674804
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,48818,-0.00165518984445506,0.00211421755935529,-0.00579905626079143,0.00248867657188132,0.433701899785579
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,48818,-0.00340380776029466,0.00228133808534123,-0.00787523040756346,0.00106761488697415,0.135705885568929
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,48818,-0.00645835477990029,0.00226927159212561,-0.0109061271004665,-0.00201058245933409,0.00443077885710288
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,48818,-0.00206747495897137,0.00209489697881094,-0.00617347303744082,0.00203852311949807,0.323696286261541
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24009.Traffic intensity on the nearest road,50706,-0.14520122211435,0.077913325943611,-0.297911340963828,0.00750889673512717,0.0623852939647326
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24010.Inverse distance to the nearest road,50706,0.00234051713469701,0.00197353292586163,-0.00152760739999179,0.00620864166938581,0.235651389052365
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24011.Traffic intensity on the nearest major road,50706,0.000933132287463807,0.00199279396226273,-0.00297274387857114,0.00483900845349876,0.639607283938736
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24012.Inverse distance to the nearest major road,50706,-0.00471578976857799,0.00201571686070705,-0.0086665948155638,-0.000764984721592174,0.0193163448561242
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24013.Total traffic load on major roads,50706,-0.0512973583670735,0.0534104046841309,-0.15598175154797,0.0533870348138231,0.336843696093911
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24015.Sum of road length of major roads within 100m,50706,-0.0844232835146876,0.0518668877629644,-0.186082383530098,0.0172358165007227,0.103602087924389
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,50706,-0.0058318549202515,0.00226288542832666,-0.0102671103597718,-0.00139659948073124,0.00996639627275598
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,50706,-0.00631801399212265,0.00226190792344062,-0.0107513535220663,-0.00188467446217904,0.00522225939221726
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,50706,-0.00518228330500801,0.00223932717622582,-0.00957136457041062,-0.000793202039605406,0.0206634717161546
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,50658,-0.00193745854297154,0.00217150059056055,-0.00619359970047022,0.00231868261452715,0.372282471400544
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24020.Average daytime sound level of noise pollution,50706,-0.000591298627879271,0.00197536455833514,-0.00446301316221614,0.0032804159064576,0.764685657738952
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24021.Average evening sound level of noise pollution,50706,-0.000573493440481473,0.00197487629691785,-0.00444425098244047,0.00329726410147752,0.77151660650004
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24022.Average night-time sound level of noise pollution,50706,-0.000607463991599325,0.00197534792759473,-0.00447914592968499,0.00326421794648634,0.758448062657326
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,50706,-0.000610299905479297,0.00197508808116925,-0.00448147254457102,0.00326087273361242,0.757324814989107
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,50706,-0.000597990200818772,0.00197514803127895,-0.00446928034212551,0.00327329994048797,0.762077282070411
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2405.Number of children fathered,35841,-0.137269284124,0.0573826582468892,-0.249739294287903,-0.024799273960097,0.016764231311093
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",47657,0.00586343658737807,0.00233197499923264,0.00129276558888209,0.010434107585874,0.0119312319359709
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",47657,-0.00298683891488415,0.00212565804314579,-0.0071531286794499,0.0011794508496816,0.159993856173247
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24502.Water percentage, buffer 1000m",47657,0.00129142969737078,0.00207385867323152,-0.002773333302163,0.00535619269690457,0.533475637793545
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",47657,0.00347924184137825,0.00219945752196629,-0.000831694901675682,0.00779017858443218,0.113693996760412
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",47657,-0.000938887067654824,0.00214946800274794,-0.0051518443530408,0.00327407021773115,0.662260549780548
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24505.Water percentage, buffer 300m",47657,0.00202066556206596,0.00208450525944644,-0.00206496474644906,0.00610629587058099,0.332368385617169
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",50802,0.0044371185085656,0.00222925878480371,6.77712903503257e-05,0.00880646572678088,0.0465568867688155
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",50802,0.000540738240602348,0.00210189400630968,-0.00357897401176462,0.00466045049296931,0.796978201461866
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24508.Distance (Euclidean) to coast,50802,0.00146212003390095,0.00201354368971255,-0.00248442559793565,0.00540866566573755,0.467757607964765
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28505,0.070833451686381,0.0886402064475492,-0.102901352950815,0.244568256323577,0.424266337080404
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2704.Years since last cervical smear test,35233,0.0645554905896393,0.053745215714568,-0.0407851322109139,0.169896113390193,0.229722185642502
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2714.Age when periods started (menarche),38474,0.065572487475684,0.0483690707455329,-0.0292308911855605,0.160375866136929,0.175225207873424
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2734.Number of live births,38935,-0.113665442907773,0.046045454803836,-0.203914534323292,-0.0234163514922544,0.0135772375640399
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2744.Birth weight of first child,35187,-0.239753028012689,0.0523140642174302,-0.342288593878852,-0.137217462146526,4.63354747323458e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2754.Age at first live birth,33215,-0.0157091948506214,0.00332368059716434,-0.0222236088210635,-0.00919478088017927,2.31818230374262e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2764.Age at last live birth,33195,-0.0143202626203131,0.00333088255760935,-0.0208487924332274,-0.00779173280739874,1.73125941185811e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2794.Age started oral contraceptive pill,36728,0.006748446679251,0.00326019389683376,0.000358466641456832,0.0131384267170452,0.038476691262199
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2804.Age when last used oral contraceptive pill,35579,-0.00595923849443774,0.0028901800637096,-0.0116239914193086,-0.000294485569566919,0.0392400366999804
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2867.Age started smoking in former smokers,29135,-0.00219334196078827,0.00456546488238224,-0.0111416531302575,0.00675496920868091,0.630948492140277
EPHA2,Ephrin type-A receptor 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36013,0.00529326550578412,0.0662737440937871,-0.124603272918039,0.135189803929607,0.936342186640926
EPHA2,Ephrin type-A receptor 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36009,0.0431422247720552,0.0733744664853186,-0.100671729539169,0.18695617908328,0.556561167224594
EPHA2,Ephrin type-A receptor 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36031,0.108727855150983,0.0748196014042829,-0.0379185636014119,0.255374273903377,0.146193979608084
EPHA2,Ephrin type-A receptor 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36001,0.0967339269116674,0.0731872858650516,-0.0467131533838338,0.240181007207169,0.186282547930616
EPHA2,Ephrin type-A receptor 2,Mental health,X28739.Difficulty with standing for long periods,36041,0.314718735585795,0.0684604717414636,0.180536210972527,0.448901260199064,4.32749220506111e-06
EPHA2,Ephrin type-A receptor 2,Mental health,X28740.Difficulty with taking care of household responsibilities,36066,0.351988624578545,0.0758374596343102,0.203347203695297,0.500630045461793,3.49736343894451e-06
EPHA2,Ephrin type-A receptor 2,Mental health,X28741.Difficulty learning a new task,35977,0.154549642606259,0.0860748019174633,-0.0141569691519689,0.323256254364487,0.0725946669005348
EPHA2,Ephrin type-A receptor 2,Mental health,X28742.Difficulty with joining in community activities,35553,0.264127313731205,0.082799517622207,0.101840259191679,0.426414368270731,0.00142667175193313
EPHA2,Ephrin type-A receptor 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35981,0.16731984459574,0.0708047844982662,0.0285424669791381,0.306097222212341,0.0181377473298578
EPHA2,Ephrin type-A receptor 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36063,0.344099987400883,0.0954290189614081,0.157059110236523,0.531140864565243,0.000312408729167981
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28988,0.13034117534688,0.0835558163138499,-0.0334282246282654,0.294110575322026,0.11883828357158
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2897.Age stopped smoking,29138,0.0111417863039304,0.00546972259743006,0.000421130012967522,0.0218624425948933,0.0417005441130352
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34759,0.00286702165277381,0.00596105806001516,-0.00881665214485589,0.0145506954504035,0.630555635575674
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34759,0.00112481458514439,0.00641098910990548,-0.0114407240702703,0.0136903532405591,0.860728512609579
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34759,-0.0218383243014974,0.0214250180873929,-0.0638313597527874,0.0201547111497926,0.308087544538039
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34759,-0.01664059758971,0.0210980679458228,-0.0579928107635228,0.0247116155841027,0.430289244709851
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34759,-0.00521397638563178,0.0226203577073864,-0.049549877492109,0.0391219247208455,0.817708141483175
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34759,-0.0263371889723662,0.0195170834401065,-0.0645906725149749,0.0119162945702424,0.177222790315208
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34759,-0.00729097163826299,0.00884975825060967,-0.024636497809458,0.010054554532932,0.410036508603442
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34759,0.00198524085843736,0.0163039406493836,-0.0299704828143545,0.0339409645312292,0.903087790085388
EPHA2,Ephrin type-A receptor 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34689,0.0720207958250473,0.0769282862769345,-0.0787586452777444,0.222800236927839,0.349187529548192
EPHA2,Ephrin type-A receptor 2,Mental health,X29003.Recent feelings of depression,34686,0.200111137884413,0.0740264888091219,0.0550192198185343,0.345203055950292,0.00687749819099182
EPHA2,Ephrin type-A receptor 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34695,0.0582452226723222,0.0607986173080113,-0.0609200672513799,0.177410512596024,0.338082916248796
EPHA2,Ephrin type-A receptor 2,Mental health,X29005.Recent feelings of tiredness or low energy,34701,0.144897788664162,0.0617498817298728,0.0238680204736118,0.265927556854713,0.0189671818592707
EPHA2,Ephrin type-A receptor 2,Mental health,X29006.Recent poor appetite or overeating,34705,0.195540680981564,0.0815045538301701,0.0357917554744306,0.355289606488697,0.0164504905834078
EPHA2,Ephrin type-A receptor 2,Mental health,X29007.Recent feelings of inadequacy,34668,0.141415018135376,0.0794873880069435,-0.0143802623582334,0.297210298628985,0.0752535205689421
EPHA2,Ephrin type-A receptor 2,Mental health,X29008.Recent trouble concentrating on things,34700,0.0449643340972102,0.0798055026448497,-0.111454451086695,0.201383119281116,0.573157866774123
EPHA2,Ephrin type-A receptor 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34692,0.174714719459018,0.14024508254894,-0.100165642336904,0.449595081254939,0.212871598575592
EPHA2,Ephrin type-A receptor 2,Mental health,X29010.Recent thoughts of suicide or self-harm,34629,0.329942000035474,0.152414287659015,0.0312099962238049,0.628674003847143,0.0304271423997337
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#0.Substances taken for depression_None of options listed,32388,-0.0023367818821063,0.0123676044507635,-0.0265772866056027,0.0219037228413901,0.850141379504309
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32388,-0.0230023820546276,0.0218827784172628,-0.0658926277524627,0.0198878636432075,0.293213202467399
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32388,0.000495913977202009,0.012156726549321,-0.0233312700594672,0.0243230980138713,0.967461571148804
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32388,-0.0229794165452928,0.0343023987941746,-0.0902121181818751,0.0442532850912895,0.502935224851904
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32388,-0.00248548798177406,0.02083901146786,-0.0433299504587797,0.0383589744952316,0.905063534190265
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32388,0.0253857372661067,0.0223300471647563,-0.0183811551768157,0.0691526297090292,0.255636251070765
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32388,0.0430738801096421,0.025629709353593,-0.00716035022340009,0.0933081104426844,0.0928727792892239
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32388,-0.0202907315671515,0.0312457639948059,-0.0815324289969711,0.0409509658626682,0.516102886808056
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32388,0.0294988633573938,0.0247398115830608,-0.0189911673454054,0.077988894060193,0.233151683942174
EPHA2,Ephrin type-A receptor 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32388,0.00109296505946681,0.0125542577619029,-0.0235133801538628,0.0256993102727964,0.93062640981789
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32388,-0.0047439257313039,0.0183915024574824,-0.0407912705479694,0.0313034190853616,0.796458531737036
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32388,-0.0460010780318897,0.0290295734214936,-0.102899041938017,0.0108968858742377,0.113087933135774
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32388,-0.0276446381129837,0.0358627554239974,-0.0979356387440185,0.0426463625180512,0.440819960743989
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32388,-0.0385804453983013,0.0223819368419567,-0.0824490416085366,0.00528815081193387,0.0847926028219416
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32388,0.0364924004019709,0.0379337413460028,-0.0378577326361947,0.110842533440136,0.336075009161197
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32388,0.0023945996019224,0.0362978059548731,-0.0687491000696288,0.0735382992734736,0.947402524991244
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32388,0.00483032974429408,0.0191484539757543,-0.0327006400481844,0.0423612995367726,0.800848574797001
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32388,-0.0210884666265359,0.0189761942321079,-0.0582818073214674,0.0161048740683955,0.266465535672246
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32388,-0.0124612150637573,0.0269434817523405,-0.0652704392983447,0.0403480091708302,0.643738466876819
EPHA2,Ephrin type-A receptor 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34538,0.111189859945319,0.0706901276719984,-0.0273627902917977,0.249742510182436,0.115767158602742
EPHA2,Ephrin type-A receptor 2,Mental health,X29059.Recent inability to stop or control worrying,34542,0.123532951187432,0.0739924580472009,-0.0214922665850819,0.268558168959946,0.0950408335232815
EPHA2,Ephrin type-A receptor 2,Mental health,X29060.Recent worrying too much about different things,34535,0.108661193576523,0.0679443754360012,-0.0245097822780397,0.241832169431085,0.109790901006242
EPHA2,Ephrin type-A receptor 2,Mental health,X29061.Recent trouble relaxing,34542,0.0713978258761608,0.0716996216362946,-0.0691334325309767,0.211929084283298,0.319374346122047
EPHA2,Ephrin type-A receptor 2,Mental health,X29062.Recent restlessness,34544,0.139297157506011,0.099674681996161,-0.0560652192064643,0.334659534218487,0.162286895157337
EPHA2,Ephrin type-A receptor 2,Mental health,X29063.Recent easy annoyance or irritability,34526,0.0543293648071108,0.0722963440846272,-0.0873714695987584,0.19603019921298,0.452379516440396
EPHA2,Ephrin type-A receptor 2,Mental health,X29064.Recent feelings of foreboding,34519,0.0577558700603008,0.082883228437452,-0.104695257677105,0.220206997797707,0.485921745413394
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32388,-0.0177545495582327,0.0125002370102036,-0.0422550140982317,0.00674591498176629,0.155546141855535
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32388,-0.018544367123315,0.0202949355360227,-0.0583224407739195,0.0212337065272895,0.360877429248884
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32388,-0.042010954711981,0.0267275037457013,-0.0943968620535555,0.0103749526295935,0.11602827316982
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32388,-0.0381991231224767,0.0298519893316485,-0.0967090222125077,0.0203107759675543,0.200714560211989
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32388,-0.00832701715552198,0.0188486648957076,-0.0452704003511088,0.0286163660400649,0.658657541730507
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32388,-0.0203331096156519,0.020312528175705,-0.0601456648400337,0.0194794456087298,0.316848809650166
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32388,-0.0190226876753555,0.0202804414698342,-0.0587723529562306,0.0207269776055196,0.348280258587433
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32388,-0.0120596612402207,0.0184850264061056,-0.0482903129961876,0.0241709905157463,0.514159701348208
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32388,-0.0133010851596051,0.0246017558538796,-0.0615205266332091,0.0349183563139989,0.588758880602452
EPHA2,Ephrin type-A receptor 2,Mental health,X29076.Felt loved as a child,34492,-0.0534302048993535,0.0637056132717487,-0.178293206911981,0.0714327971132741,0.401653833971375
EPHA2,Ephrin type-A receptor 2,Mental health,X29077.Physically abused by family as a child,34498,0.070202503298348,0.082333699116933,-0.0911715469708406,0.231576553567537,0.393868081640161
EPHA2,Ephrin type-A receptor 2,Mental health,X29078.Felt hated by family member as a child,34484,0.290832997132711,0.0829993365074222,0.128154297578163,0.453511696687258,0.00046014358402466
EPHA2,Ephrin type-A receptor 2,Mental health,X29079.Sexually molested as a child,34403,0.0672027806893131,0.11407728433131,-0.156388696600055,0.290794257978681,0.55580768609072
EPHA2,Ephrin type-A receptor 2,Mental health,X29080.Someone to take to doctor when needed as a child,34480,-0.0855233509494663,0.0954670035152463,-0.272638677839349,0.101591975940417,0.370357467293254
EPHA2,Ephrin type-A receptor 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34483,-0.0966971676790606,0.114776991147978,-0.321660070329098,0.128265734970977,0.399539038769202
EPHA2,Ephrin type-A receptor 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34424,0.145583439270917,0.089385868377523,-0.0296128627490279,0.320779741290862,0.103404763186219
EPHA2,Ephrin type-A receptor 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34490,-0.0434113069605633,0.100341969917375,-0.240081567998618,0.153258954077491,0.665289758163937
EPHA2,Ephrin type-A receptor 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34453,0.0304774752917495,0.141061719725403,-0.24600349537004,0.306958445953539,0.828946906685297
EPHA2,Ephrin type-A receptor 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34452,-0.0192717805633267,0.137285876206171,-0.288352097927421,0.249808536800768,0.888364792301414
EPHA2,Ephrin type-A receptor 2,Mental health,X29086.Experienced a violent or sexual assault,34489,0.0534508214140646,0.110705902047678,-0.163532746599385,0.270434389427514,0.629234790426497
EPHA2,Ephrin type-A receptor 2,Mental health,X29087.Experienced a life-threatening injury or illness,34497,0.33706326728584,0.0764470077868466,0.187227132023621,0.48689940254806,1.04815230083049e-05
EPHA2,Ephrin type-A receptor 2,Mental health,X29088.Experienced a marital separation or divorce,34498,-0.0797141397732972,0.0690527007663449,-0.215057433275333,0.0556291537287388,0.248363917841054
EPHA2,Ephrin type-A receptor 2,Mental health,X29089.Experienced the death of a spouse or partner,34508,0.0428150024579066,0.108605937289649,-0.170052634629805,0.255682639545618,0.693424002402103
EPHA2,Ephrin type-A receptor 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34494,0.0733985392642174,0.0851914823065765,-0.0935767660566726,0.240373844585107,0.38894287844075
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34503,-0.810109490523402,0.0589225584675199,-0.925597705119741,-0.694621275927063,1.19907066552741e-42
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33433,-0.650008876556985,0.0668890789504878,-0.781111471299942,-0.518906281814029,3.20964381785288e-22
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33448,-0.731208403519793,0.067265975120367,-0.863049714755713,-0.599367092283874,2.30284599149166e-27
EPHA2,Ephrin type-A receptor 2,Mental health,X29104.Ever used cannabis,34492,-0.260835553848937,0.0777511183102911,-0.413227745737108,-0.108443361960767,0.000797147162228313
EPHA2,Ephrin type-A receptor 2,Mental health,X29108.Ever thought that life not worth living,34442,0.142986429115775,0.0699287876130072,0.00592600539428098,0.280046852837269,0.0409048505073363
EPHA2,Ephrin type-A receptor 2,Mental health,X29109.Ever contemplated self-harm,34461,0.0970364732783729,0.0917241205742938,-0.082742803047243,0.276815749603989,0.290117556761606
EPHA2,Ephrin type-A receptor 2,Mental health,X29111.Ever self-harmed,34480,0.153963425929537,0.144495746415283,-0.129248237044418,0.437175088903491,0.286663909796489
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34486,0.284395354529724,0.0986969255214155,0.0909493805077491,0.477841328551698,0.00396577705625831
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33068,0.00518020435706312,0.0252729569494756,-0.0443547912639091,0.0547151999780353,0.837599897491489
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33068,-0.0150431541119048,0.0200489230835635,-0.0543390433556892,0.0242527351318796,0.453079785638619
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33068,-0.0267317528390094,0.0207645291184232,-0.0674302299111188,0.0139667242331,0.197995682724649
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33068,-0.00429313760039273,0.0276336217909327,-0.0584550363106209,0.0498687611098354,0.876541546161118
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34479,-0.0311456585690455,0.0646208232857384,-0.157802472209093,0.0955111550710019,0.629833230357881
EPHA2,Ephrin type-A receptor 2,Health and medical history,X29153.Pain or discomfort today,34493,0.18270609851126,0.0620559029320573,0.0610765287644276,0.304335668258092,0.00324472783939809
EPHA2,Ephrin type-A receptor 2,Mental health,X29154.Anxiety or depression today,34493,0.151076522959401,0.0756568424972203,0.00278911166484969,0.299363934253953,0.0458652706378398
EPHA2,Ephrin type-A receptor 2,Mental health,X29166.Frequency of confiding in someone close,34262,-0.161807525101281,0.0604265548817196,-0.280243572669452,-0.0433714775331106,0.00742337838696248
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34460,0.0136904202927719,0.00618271396491708,0.00157230092153446,0.0258085396640094,0.0268289350103381
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34460,-0.00770235729925649,0.00614580959272717,-0.0197481441010017,0.00434342950248877,0.210135193669548
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34460,-0.0553145518966555,0.00763533995831327,-0.0702798182149495,-0.0403492855783615,4.64058486551705e-13
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34460,0.0191055139627163,0.00912847284250191,0.00121370719141252,0.03699732073402,0.0363765802579874
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34460,0.016536660667172,0.0141866797780271,-0.0112692316977611,0.0443425530321052,0.243783426375303
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34460,0.00338900656505788,0.00666200174363557,-0.00966851685246784,0.0164465299825836,0.610968240008818
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34459,0.00695438530264097,0.00729329884504163,-0.00734048043364063,0.0212492510389226,0.340342928221067
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34459,-0.022892705904551,0.010372532686791,-0.0432228699706612,-0.00256254183844071,0.0273318674700773
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34459,-0.0247667870765596,0.0166618572317885,-0.0574240272508652,0.00789045309774589,0.137193535630374
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34459,0.030866902349323,0.0163337309191807,-0.00114721025227116,0.0628810149509171,0.0588167475570116
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34459,0.0017992302492682,0.0219724831739293,-0.0412668367716332,0.0448652972701696,0.934739221537246
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34459,-0.000944898215942647,0.0109130735303931,-0.0223345223355131,0.0204447259036278,0.931003771949087
EPHA2,Ephrin type-A receptor 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34277,-0.20145265836176,0.0736974871994555,-0.345899733272693,-0.0570055834508278,0.00627694412919578
EPHA2,Ephrin type-A receptor 2,Mental health,X29172.Freuency of feeling that lacks companionship,34412,0.200142940660068,0.0672483010862841,0.0683362705309514,0.331949610789185,0.00292527040654737
EPHA2,Ephrin type-A receptor 2,Mental health,X29173.Frequency of feeling left out,34368,0.199964752829294,0.0691936969886527,0.064345106731535,0.335584398927053,0.00386119548016008
EPHA2,Ephrin type-A receptor 2,Mental health,X29174.Frequency of feeling isolated from others,34401,0.159269740043482,0.0714178940335317,0.0192906677377601,0.299248812349204,0.0257611331383858
EPHA2,Ephrin type-A receptor 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34477,-0.132880018779858,0.0603367000316892,-0.251139950841969,-0.0146200867177471,0.027664957753987
EPHA2,Ephrin type-A receptor 2,Mental health,X29176.Ability to make it through stressful events,34477,0.113411665873076,0.0586202894775951,-0.00148410150301059,0.228307433249162,0.0530557717999977
EPHA2,Ephrin type-A receptor 2,Mental health,X29177.Quick recovery from stressful events,34477,-0.159159625005454,0.0595862977768658,-0.275948768648111,-0.0423704813627969,0.00757234855207494
EPHA2,Ephrin type-A receptor 2,Mental health,X29178.Hard to snap back when something bad happens,34477,0.103098994887188,0.0589787476391948,-0.0124993504856336,0.21869734026001,0.0804807739091114
EPHA2,Ephrin type-A receptor 2,Mental health,X29179.Comes through difficult times with little trouble,34477,-0.0824692290769831,0.0596644851443992,-0.199411619960006,0.0344731618060394,0.166934355327608
EPHA2,Ephrin type-A receptor 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34477,0.116959155191785,0.0592930658516698,0.00074474612251188,0.233173564261058,0.0485715791000187
EPHA2,Ephrin type-A receptor 2,Mental health,X29181.General happiness,34413,0.131370516920652,0.0616996160676918,0.0104392694279757,0.252301764413328,0.0332612197993239
EPHA2,Ephrin type-A receptor 2,Mental health,X29182.Belief that own life is meaningful,34313,-0.149388077272334,0.0611240838424922,-0.269191281603619,-0.0295848729410493,0.0145413069619503
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28695,-0.0989096362997863,0.0806854695523834,-0.257053156622458,0.0592338840228852,0.220308530074421
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2946.Father's age,33704,-0.0111514866724348,0.00476947133055842,-0.0204996504803293,-0.00180332286454032,0.0194021341639792
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2966.Age high blood pressure diagnosed,28888,-0.0441515576412058,0.00904143143234339,-0.0618727632485988,-0.0264303520338127,1.07585341966307e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50251,0.00200008267877495,0.00207041880536224,-0.00205793817973505,0.00605810353728495,0.334038988311165
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50251,-0.00320736516414186,0.00244134761662828,-0.00799240649273329,0.00157767616444956,0.188935600774363
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30020.Haemoglobin concentration,50251,-0.021821672122874,0.00259993647556516,-0.0269175476149817,-0.0167257966307663,4.96658436753084e-17
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30030.Haematocrit percentage,50251,-0.0154554634242935,0.00254805914278584,-0.0204496593441538,-0.0104612675044333,1.33262991748267e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30040.Mean corpuscular volume,50251,-0.0134061024357864,0.00206774551654757,-0.0174588836482197,-0.00935332122335317,9.1238503200109e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50250,-0.0185709723834791,0.00206830485460325,-0.0226248498985014,-0.0145170948684567,2.91426964941079e-19
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50250,-0.0132250056681836,0.00201838414898477,-0.0171810386001937,-0.00926897273617343,5.77109956505471e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50251,0.0300683454217079,0.00196525525944831,0.0262164451131892,0.0339202457302266,1.28720657599986e-52
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30080.Platelet count,50251,-0.016285984026683,0.00208714752418992,-0.0203767931740952,-0.0121951748792708,6.26882015815345e-15
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30090.Platelet crit,50251,-0.0128793623102593,0.00213671684498209,-0.0170673273264242,-0.00869139729409443,1.68576122068992e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50251,0.0105914259096636,0.0020119635645544,0.00664797732313696,0.0145348744961902,1.41883666857326e-07
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30110.Platelet distribution width,50251,0.0043308053778389,0.00199356980731276,0.000423408555505891,0.00823820220017191,0.0298353458615315
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30120.Lymphocyte count,50215,-0.00847828420204723,0.00210943794810996,-0.0126127825803427,-0.00434378582375171,5.85546531400493e-05
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30130.Monocyte count,50215,0.0114382867629616,0.00209299929444274,0.00733600814585384,0.0155405653800694,4.6704086902806e-08
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30140.Neutrophill count,50215,0.000766791798303928,0.00205055254701591,-0.00325229119384726,0.00478587479045512,0.708448996597901
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30150.Eosinophill count,50215,0.0182535616212431,0.00200889479692004,0.0143161278192799,0.0221909954232064,1.09396042593812e-19
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30160.Basophill count,50215,-0.0189371713863365,0.038781631581348,-0.0949491692857786,0.0570748265131056,0.625339585553286
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30170.Nucleated red blood cell count,50215,0.185031731053175,0.163119123364624,-0.134681750741488,0.504745212847838,0.256664369990063
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30180.Lymphocyte percentage,50215,-0.00948046718924304,0.00206847308490413,-0.0135346744356551,-0.00542625994283095,4.5975684457605e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30190.Monocyte percentage,50215,0.01122968021155,0.0020670708208309,0.00717822140272148,0.0152811390203786,5.60132946524066e-08
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30200.Neutrophill percentage,50215,-0.000683575376457376,0.00203897131430356,-0.00467995915249235,0.00331280839957759,0.73743538656897
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30210.Eosinophill percentage,50215,0.0184555589670267,0.0019834178654687,0.014568059950708,0.0223430579833453,1.44178578526654e-20
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30220.Basophill percentage,50215,0.00315055512008432,0.00196950595853593,-0.000709676558646109,0.00701078679881475,0.109684301661417
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50215,0.195347747788678,0.163060544937772,-0.124250920289355,0.514946415866711,0.230924890208123
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30240.Reticulocyte percentage,49775,-0.0011350725462089,0.00212555853502312,-0.00530116727485421,0.00303102218243642,0.593338208775621
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30250.Reticulocyte count,49775,-0.00216263535947963,0.0021789454811623,-0.00643336850255773,0.00210809778359847,0.320955792733605
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30260.Mean reticulocyte volume,49775,0.00668411578587621,0.00205342397322876,0.00265940479834784,0.0107088267734046,0.00113494837024877
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30270.Mean sphered cell volume,49775,-0.0052878742369713,0.00206493169297963,-0.00933514035521137,-0.00124060811873124,0.0104487994728891
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30280.Immature reticulocyte fraction,49775,0.00512851493910035,0.00214017279950709,0.000933776252066454,0.00932325362613424,0.0165681742476912
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,49775,0.000751850875906244,0.0021725332646304,-0.00350631432276935,0.00501001607458184,0.729292126138244
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30300.High light scatter reticulocyte count,49775,-0.000102948955849124,0.00220964036005135,-0.00443384406154976,0.00422794614985152,0.962839707823055
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30500.Microalbumin in urine,31780,0.0565208770827846,0.00419698831470019,0.0482947799859722,0.0647469741795969,6.8778625059428e-41
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50360,-0.000106875107958149,0.00211257538301853,-0.00424752285867446,0.00403377264275816,0.959652643181007
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30520.Potassium in urine,50304,-0.0115734614274657,0.00195437596078006,-0.0154040383105946,-0.00774288454433676,3.22330300431122e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30530.Sodium in urine,50302,-0.00735182410063269,0.00204120725899393,-0.0113525903282608,-0.00335105787300458,0.000316717416478008
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30600.Albumin,47653,-0.0631326784003679,0.00216427262674587,-0.0673746527487898,-0.058890704051946,7.91218712270681e-184
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30610.Alkaline phosphatase,49852,0.0675095116630051,0.00203505859235102,0.0635207968219971,0.0714982265040131,2.22418883188353e-236
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30620.Alanine aminotransferase,49846,0.00891701280415833,0.00219725180209795,0.00461039927204636,0.0132236263362703,4.9584830451264e-05
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30630.Apolipoprotein A,47519,-0.0235547174658503,0.00239238487177846,-0.028243791814536,-0.0188656431171645,7.91426875451823e-23
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30640.Apolipoprotein B,49694,-0.0188958515256014,0.00211041406192712,-0.0230322630869785,-0.0147594399642242,3.66593959560018e-19
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30650.Aspartate aminotransferase,49769,0.0254307930191304,0.00205553985071556,0.0214019349117279,0.0294596511265329,4.66382446220735e-35
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30660.Direct bilirubin,45807,0.000717533224527337,0.00225568882535355,-0.00370361687316563,0.0051386833222203,0.750412577911714
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30670.Urea,49844,0.0487273400247073,0.0021439362304028,0.0445252250131178,0.0529294550362968,3.01582097305901e-113
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30680.Calcium,47649,-0.0182779157674022,0.00214218360438541,-0.0224765956319976,-0.0140792359028068,1.51797638699853e-17
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30690.Cholesterol,49857,-0.0221540887499094,0.00216843444622003,-0.0264042202645006,-0.0179039572353181,1.85820983065927e-24
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30700.Creatinine,49847,0.108538021451756,0.00253258990895694,0.103574145230201,0.113501897673312,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30710.C-reactive protein,49778,0.0136820262398345,0.0022560419380146,0.00926018404132584,0.0181038684383431,1.34099473188919e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30720.Cystatin C,49850,0.191086626446054,0.00210470032861283,0.186961413801973,0.195211839090135,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30730.Gamma glutamyltransferase,49842,-0.00945085302869349,0.00223389462395143,-0.0138292864916383,-0.00507241956574869,2.33802557363609e-05
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30740.Glucose,47616,-0.00497590028607335,0.0021804976688529,-0.00924967571702504,-0.000702124855121659,0.0224980172278817
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),49628,0.013331743118901,0.0021781397735067,0.0090625891628279,0.0176008970749741,9.45082281906479e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30760.HDL cholesterol,47633,-0.0307714633747461,0.00252653528854241,-0.0357234725402892,-0.025819454209203,5.06035094797426e-34
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30770.IGF-1,49735,-0.00440211112347639,0.0021371249416458,-0.00859087600910217,-0.000213346237850617,0.0394249061386578
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30780.LDL direct,49805,-0.0184421203272037,0.00214748855560354,-0.0226511978961867,-0.0142330427582208,9.35740404512366e-18
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30790.Lipoprotein A,44658,-0.00174003947667467,0.00224502602816568,-0.00614029049187941,0.00266021153853007,0.438310490497561
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30810.Phosphate,47587,0.00701998643944766,0.00214308943859418,0.00281953113980307,0.0112204417390922,0.00105574547932371
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30830.SHBG,47408,0.0324299048333944,0.00248605143583123,0.0275572440191652,0.0373025656476236,9.27858484650423e-39
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30840.Total bilirubin,49756,-0.00783751064435801,0.00210531725869998,-0.01196393247141,-0.00371108881730605,0.000197503852741933
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30850.Testosterone,47757,-0.0021982069673434,0.00351309835701651,-0.00908387974709577,0.00468746581240897,0.531506257084834
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30860.Total protein,47633,-0.039736214575286,0.00216195080403312,-0.0439736381511909,-0.0354987909993811,6.30504485204313e-75
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30870.Triglycerides,49835,0.0133185048193155,0.00215908076470424,0.00908670652049519,0.0175503031181358,6.99139390109353e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30880.Urate,49824,0.0297328183012202,0.00259316709835151,0.0246502107884512,0.0348154258139892,2.3178547127694e-30
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30890.Vitamin D,48795,0.00301967608953538,0.00224718988937344,-0.00138481609363656,0.00742416827270732,0.179039357542389
EPHA2,Ephrin type-A receptor 2,Physical measures,X3137.Number of measurements made,48929,0.12936586176535,0.0451887275568048,0.0407959557540124,0.217935767776687,0.00420276059578892
EPHA2,Ephrin type-A receptor 2,Physical measures,X3143.Ankle spacing width,39289,0.0205172653047753,0.00371006213747169,0.0132455435153308,0.0277889870942198,3.25121505454793e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39288,-0.0102779692850568,0.00285858165099251,-0.0158807893210021,-0.00467514924911148,0.000324806050708331
EPHA2,Ephrin type-A receptor 2,Physical measures,X3146.Speed of sound through heel,39289,-0.0145711118243501,0.00277478666971583,-0.0200096936969931,-0.0091325299517071,1.53071824612026e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39289,-0.0134050389909416,0.00280262559023506,-0.0188981851478024,-0.00791189283408092,1.7426942614262e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X3148.Heel bone mineral density (BMD),39280,-0.0134624079700675,0.00280528315907032,-0.0189607629618454,-0.00796405297828971,1.60995431893305e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3526.Mother's age at death,34940,-0.0011074660100736,0.00380202421444785,-0.00855943347039138,0.00634450145024419,0.770840141252474
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3581.Age at menopause (last menstrual period),30176,-0.0074024669938655,0.00517058344355668,-0.0175368105432366,0.00273187655550559,0.152293418491158
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30119,0.00699716814921278,0.00454287973578988,-0.00190687613293539,0.015901212431361,0.123550104871323
EPHA2,Ephrin type-A receptor 2,Physical measures,X4100.Ankle spacing width (left),32507,0.0105534566789893,0.00475930908987139,0.00122521086284133,0.0198817024951372,0.0266193075797484
EPHA2,Ephrin type-A receptor 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32506,-0.012761586616791,0.00368289990969573,-0.0199800704397946,-0.00554310279378734,0.000532622847856545
EPHA2,Ephrin type-A receptor 2,Physical measures,X4103.Speed of sound through heel (left),32507,-0.0168846360247257,0.00359010995071873,-0.0239212515281344,-0.00984802052131702,2.6021519338418e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32507,-0.0160994777462707,0.0036239112617429,-0.0232023438192867,-0.00899661167325458,8.99967908738236e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32500,-0.0157401584426251,0.00362886589511182,-0.0228527355970442,-0.0086275812882059,1.45758089223546e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32507,-0.0160930674519379,0.00362395452041566,-0.0231960183119526,-0.00899011659192319,9.07604237888569e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X4119.Ankle spacing width (right),32502,0.0128895546763639,0.00468445765990188,0.0037080176629562,0.0220710916897716,0.00594362131780364
EPHA2,Ephrin type-A receptor 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32502,-0.0096370481548841,0.00371124004690806,-0.0169110786468239,-0.00236301766294431,0.00942782585345977
EPHA2,Ephrin type-A receptor 2,Physical measures,X4122.Speed of sound through heel (right),32502,-0.0148198290046309,0.0036079585954825,-0.0218914278517766,-0.00774823015748516,4.03585968337014e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32502,-0.0134445976067492,0.00364545202297743,-0.020589683571785,-0.00629951164171344,0.000227368168501806
EPHA2,Ephrin type-A receptor 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32494,-0.0134493429365497,0.00365466432268481,-0.020612485009012,-0.0062862008640875,0.000234609306324394
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32502,-0.0134455786637992,0.00364546734903448,-0.0205906946679068,-0.00630046265969158,0.000227142065970647
EPHA2,Ephrin type-A receptor 2,Physical measures,X4194.Pulse rate,32794,0.00908149114701861,0.00347730381525205,0.0022659756691246,0.0158970066249126,0.00902578374057847
EPHA2,Ephrin type-A receptor 2,Physical measures,X4195.Pulse wave reflection index,32794,-0.00358904052998841,0.00340103541810273,-0.0102550699494698,0.00307698888949294,0.291326376231217
EPHA2,Ephrin type-A receptor 2,Physical measures,X4196.Pulse wave peak to peak time,32789,-0.000227377251522151,0.003649671424321,-0.00738073324319132,0.00692597874014702,0.950324729053304
EPHA2,Ephrin type-A receptor 2,Physical measures,X4198.Position of the pulse wave peak,32794,-0.000901164583630875,0.00349368576982401,-0.00774878869248594,0.00594645952522419,0.796458431052275
EPHA2,Ephrin type-A receptor 2,Physical measures,X4199.Position of pulse wave notch,32794,0.00725986035252635,0.00344003832357081,0.000517385238327556,0.0140023354667251,0.0348515503975855
EPHA2,Ephrin type-A receptor 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,32794,0.00156978968583059,0.00358385127506911,-0.00545455881330488,0.00859413818496605,0.661384165037147
EPHA2,Ephrin type-A receptor 2,Physical measures,X4269.Number of triplets attempted (left),32669,0.0718496412535378,0.215084075805168,-0.349715147324592,0.493414429831668,0.738346966948015
EPHA2,Ephrin type-A receptor 2,Physical measures,X4270.Volume level set by participant (left),32586,0.00332003825698731,0.0619777968894174,-0.118156443646271,0.124796520160245,0.957280429337205
EPHA2,Ephrin type-A receptor 2,Physical measures,X4276.Number of triplets attempted (right),32678,0.0850085794218248,0.210115259988422,-0.326817330155483,0.496834488999133,0.685795573401282
EPHA2,Ephrin type-A receptor 2,Physical measures,X4277.Volume level set by participant (right),32582,0.018316142472896,0.062016626199561,-0.103236444878244,0.139868729824036,0.767739322248637
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4288.Time to answer,32831,-0.00588257734996845,0.00393044434147684,-0.0135862482592631,0.00182109355932616,0.13451437730676
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4290.Duration screen displayed,32831,0.00689724937589654,0.00349070753975285,5.54625979809565e-05,0.0137390361538121,0.0481979833121202
EPHA2,Ephrin type-A receptor 2,Physical measures,X46.Hand grip strength (left),51037,-0.0319783103310565,0.00280449172354225,-0.0374751141091993,-0.0264815065529137,4.75350590493339e-30
EPHA2,Ephrin type-A receptor 2,Physical measures,X47.Hand grip strength (right),51017,-0.0326025908023638,0.00277684053578571,-0.0380451982525038,-0.0271599833522238,9.38667635175841e-32
EPHA2,Ephrin type-A receptor 2,Physical measures,X48.Waist circumference,51095,-0.00158657289734269,0.00440944959292181,-0.0102290940994694,0.00705594830478406,0.718990515128414
EPHA2,Ephrin type-A receptor 2,Health and medical history,X4803.Tinnitus,32621,0.0737034593318323,0.0756560308762861,-0.0745823611856885,0.221989279849353,0.3299883889947
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4825.Noisy workplace,32753,0.0115875172474272,0.0838680253813776,-0.152793812500073,0.175968846994927,0.890114166780853
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4836.Loud music exposure frequency,32698,0.0420173040054493,0.0914139753178081,-0.137154087617455,0.221188695628353,0.645787644421257
EPHA2,Ephrin type-A receptor 2,Physical measures,X49.Hip circumference,51090,0.00456169056527628,0.00347573359357411,-0.00225074727812897,0.0113741284086815,0.18938289972521
EPHA2,Ephrin type-A receptor 2,Physical measures,X50.Standing height,51067,0.0167461853612981,0.00276067747207335,0.0113352575160343,0.0221571132065619,1.32889272355094e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,X5057.Number of older siblings,31992,-0.0376489193500088,0.0659426787776138,-0.166896569754132,0.0915987310541143,0.568060140560085
EPHA2,Ephrin type-A receptor 2,Physical measures,X51.Seated height,50942,0.00842836083641669,0.00256213093858059,0.00340658419679873,0.0134501374760346,0.00100461428580578
EPHA2,Ephrin type-A receptor 2,Eye measures,X5181.Ever had eye surgery,29922,-0.119247203973032,0.167847276357277,-0.448227865633295,0.209733457687231,0.477452072443061
EPHA2,Ephrin type-A receptor 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29908,-0.00431589100786218,0.00425857449836493,-0.0126626970246574,0.00403091500893307,0.310881471938901
EPHA2,Ephrin type-A receptor 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29906,0.00171796093019235,0.00420305077323884,-0.00652001858535577,0.00995594044574048,0.682743912290112
EPHA2,Ephrin type-A receptor 2,Eye measures,X5190.Duration at which refractometer first shown (right),29852,-0.000248578809692087,0.00414327756536907,-0.00836940283781547,0.00787224521843129,0.952161065608522
EPHA2,Ephrin type-A receptor 2,Eye measures,X5193.Duration at which refractometer first shown (left),29850,0.00384904224734046,0.00415392955589907,-0.00429265968222172,0.0119907441769026,0.354170195669767
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5199.logMAR, initial (right)",29884,0.201485139971097,0.0780307815958835,0.0485448080431655,0.354425471899029,0.0098428286478079
EPHA2,Ephrin type-A receptor 2,Eye measures,X5200.Final number of letters displayed (right),29884,-0.221705854930315,0.567178298540236,-1.33337532006918,0.889963610208547,0.695890380170284
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5201.logMAR, final (right)",29832,0.00891106582905617,0.00402256120022417,0.0010268458766168,0.0167952857814955,0.0267790103535014
EPHA2,Ephrin type-A receptor 2,Eye measures,X5202.Number of rounds to result (right),29884,0.0263976092689007,0.0748104765753797,-0.120230924818843,0.173026143356645,0.724205923206839
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5206.logMAR, initial (left)",29880,0.0985748707232427,0.0767119965685581,-0.0517806425511311,0.248930383997617,0.198841933972504
EPHA2,Ephrin type-A receptor 2,Eye measures,X5207.Final number of letters displayed (left),29880,0.27195480026075,0.524663544844159,-0.756385747633802,1.3002953481553,0.604239196997878
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5208.logMAR, final (left)",29832,0.0051704719928656,0.00402324138597001,-0.00271508112363561,0.0130560251093668,0.198789421422887
EPHA2,Ephrin type-A receptor 2,Eye measures,X5209.Number of rounds to result (left),29877,-0.00946631949222733,0.0743787875301976,-0.155248743051415,0.13631610406696,0.898729568295967
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29642,-0.00747535030777235,0.00417670896527566,-0.0156616998797127,0.000710999264167947,0.0735431336518588
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29642,-0.00702644956792718,0.00410687768274579,-0.0150759298261089,0.00102303069025457,0.0871535485080772
EPHA2,Ephrin type-A receptor 2,Eye measures,X5256.Corneal hysteresis (right),29642,0.00125970051684095,0.0042299854093251,-0.00703107088543625,0.00955047191911816,0.765864554117151
EPHA2,Ephrin type-A receptor 2,Eye measures,X5257.Corneal resistance factor (right),29642,-0.00297862043467094,0.00415700357405656,-0.0111263474398218,0.00516910657047991,0.473692694296699
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29623,-0.00876900800728858,0.00419594732000095,-0.0169930647544904,-0.000544951260086707,0.0366727037947214
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29623,-0.00671134311450051,0.00410495087473142,-0.0147570468289741,0.00133436059997308,0.102116509857355
EPHA2,Ephrin type-A receptor 2,Eye measures,X5264.Corneal hysteresis (left),29623,0.00418815737195812,0.00418516744452399,-0.00401477081930889,0.0123910855632251,0.31700691362293
EPHA2,Ephrin type-A receptor 2,Eye measures,X5265.Corneal resistance factor (left),29623,-1.60769954896553e-05,0.00410888324974882,-0.00806948816499734,0.00803733417401803,0.996878227849341
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29716,0.763608910245885,0.30072484719044,0.174188209752622,1.35302961073915,0.0111353993692751
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51007,0.0524265415129175,0.0119835358979022,0.0289388111530292,0.0759142718728057,1.2195139261583e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51007,0.0584768455673028,0.0134370282261609,0.0321402702440274,0.0848134208905782,1.35444372366912e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51007,0.102823742040319,0.0316414074252129,0.0408065834869016,0.164840900593736,0.00115684610159979
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51007,-0.0139930964087336,0.00556471506518305,-0.0248999379364924,-0.00308625488097486,0.0119220939027656
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51007,-0.00523686741497425,0.00498473653248789,-0.0150069510186505,0.00453321618870202,0.293460614488639
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37384,-0.0222357790582658,0.00588013864516817,-0.0337608508027955,-0.0107107073137362,0.000156553330990706
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37384,0.00427978099283284,0.020828104013082,-0.036543302872808,0.0451028648584736,0.837199383149532
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37384,-0.0136576159505601,0.0100349816916255,-0.0333261800661461,0.00601094816502593,0.173536182250259
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37384,0.00380694116002154,0.00635835673518492,-0.0086554380409409,0.016269320360984,0.549362742118743
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51078,0.0320591892471916,0.0111858127498643,0.0101349962574576,0.0539833822369255,0.00415936483710094
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51078,0.0320591892471916,0.0111858127498643,0.0101349962574576,0.0539833822369255,0.00415936483710094
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51078,-0.0156750152492307,0.00823411326041421,-0.0318138772396425,0.00046384674118119,0.056964015468753
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51078,-0.00868294352473667,0.0127890694835985,-0.0337495197125897,0.0163836326631164,0.497184987490919
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51078,-0.00804783532135802,0.0313167086146943,-0.0694285842061588,0.0533329135634427,0.79719448997548
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51078,-0.0196638626308195,0.0220724674811822,-0.0629258988939366,0.0235981736322977,0.373002816039236
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51078,0.0594554949459792,0.0334266241001178,-0.00606068829025179,0.12497167818221,0.0753022836765635
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51006,0.0129011183426394,0.00632141335294275,0.000511148170871608,0.0252910885144072,0.0412744177102967
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51006,0.0159505129315068,0.0109391248281602,-0.00549017173168717,0.0373911975947008,0.14482014089227
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51006,-0.00340691132851483,0.00529972244439107,-0.0137943673195213,0.00698054466249166,0.520328731986677
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51006,0.0424108030856856,0.00997715440135156,0.0228555804590365,0.0619660257123346,2.13727336670089e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51006,0.0101570765944732,0.00869395815642305,-0.00688308139211594,0.0271972345810624,0.242699500954353
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51006,0.051605730150398,0.00704433984860536,0.0377988240471315,0.0654126362536645,2.44012842440895e-13
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29895,0.0309540957881141,0.0217408978897342,-0.011658064075765,0.0735662556519932,0.154563993321427
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29895,-0.0129310364939724,0.0188214564388719,-0.0498210911141613,0.0239590181262165,0.49208582738764
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29895,0.123716968408317,0.0236241731481185,0.0774135890380045,0.170020347778629,1.68843009593148e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29895,0.0237326103895212,0.0192844121335178,-0.0140648373921737,0.0615300581712162,0.218496935322359
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,50948,0.0264471049531805,0.0175126009710998,-0.00787759295017505,0.0607718028565361,0.131010253985841
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,50948,0.0226078127378535,0.025240263661798,-0.0268631040392707,0.0720787295149776,0.370418671602059
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,50948,0.0939728691652159,0.0511226857246023,-0.00622759485500471,0.194173333185436,0.0660463370072434
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,50948,0.000239014420764957,0.0448366643742754,-0.0876408477528147,0.0881188765943447,0.995746711859482
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,50948,0.0464876604921364,0.0162931340553391,0.0145531177436717,0.0784222032406011,0.00433134075062538
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,50948,0.0145401929008812,0.0206113176265728,-0.0258579896472014,0.0549383754489638,0.480538148341063
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,50948,0.0167030635430029,0.00848809274193833,6.64017688037852e-05,0.033339725317202,0.0490985998522621
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33229,0.142245501531742,0.0162790862724767,0.110338492437688,0.174152510625797,2.78269182511065e-18
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33229,0.0524097411844887,0.0184465500626752,0.0162545030616454,0.088564979307332,0.00450456749882492
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33229,0.145573584536715,0.0235084001112318,0.0994971203187009,0.19165004875473,6.17413211540027e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33229,0.00453974450295284,0.00706122699219227,-0.009300260401744,0.0183797494076497,0.520297217452682
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35321,0.0209789643943958,0.00810472762169728,0.00509369825586909,0.0368642305329224,0.00965209215900233
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35321,-0.0241004390663808,0.0065643762252045,-0.0369666164677817,-0.01123426166498,0.000242323444804601
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35321,0.000404143408846866,0.00649318258128544,-0.0123224944504726,0.0131307812681663,0.950371846761698
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35322,0.0189743690359177,0.0159330775763974,-0.0122544630138213,0.0502032010856567,0.233725712653123
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35322,0.0652777870344857,0.0103652700457725,0.0449618577447716,0.0855937163241998,3.13066201572447e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35322,0.012114518693026,0.0129196394380367,-0.0132079746055258,0.0374370119915779,0.348427401296342
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51006,0.0125655567900618,0.0147495904931231,-0.0163436405764594,0.041474754156583,0.394262787517716
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51006,0.0169227240728479,0.00964080300269163,-0.00197324981242767,0.0358186979581235,0.0792153383736623
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51006,0.0329609779371609,0.029157648962992,-0.0241880140303034,0.0901099699046252,0.258300779117346
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51006,0.0429200401236752,0.0108874807874714,0.0215805777802314,0.0642595024671191,8.09581733975967e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51006,-0.0103389035271217,0.011977366451244,-0.03381454177156,0.0131367347173167,0.388033267041171
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51006,0.0666718183493269,0.0132084079705163,0.040783338727115,0.0925602979715388,4.50095032005231e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51006,-0.00988783551487467,0.00425834924332946,-0.0182342000318004,-0.00154147099794893,0.0202409461948632
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27922,0.081158584375019,0.0149029115404243,0.0519488777557875,0.110368290994251,5.4616817690424e-08
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27922,0.0713276075602162,0.0189662083078894,0.034153839276753,0.108501375843679,0.000171774030867115
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27922,-0.0737303308882703,0.0138601126426625,-0.100896151667889,-0.0465645101086519,1.09595900334876e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27922,0.00902571534618792,0.0115930853637136,-0.0136967319666907,0.0317481626590666,0.436294321322181
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51128,0.00933062904765924,0.0045537158030636,0.000405346073654587,0.0182559120216639,0.0404702605934026
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51128,0.00985050554633625,0.0133922271299182,-0.0163982596283035,0.036099270720976,0.462017614781204
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51128,0.00211653329630663,0.00459706505064165,-0.00689371420295101,0.0111267807955643,0.645225851877956
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51128,0.0105250971814915,0.00447069976893332,0.00176252563438216,0.0192876687286008,0.0185677091513144
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51128,0.0269776203879381,0.0064795630424943,0.0142776768246493,0.039677563951227,3.1437677702316e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51128,0.0295633963657013,0.00666737746771324,0.0164953365289833,0.0426314562024192,9.28459090173839e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51128,0.0235394731736561,0.0049279663942302,0.0138806590409649,0.0331982873063473,1.79110969351526e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51128,0.128312622351797,0.0139611187879469,0.100948829527421,0.155676415176173,4.17216627443905e-20
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42260,-0.00713382064599492,0.00479073954326723,-0.0165236701507987,0.00225602885880886,0.136482002224324
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42260,-0.0366181757038402,0.00502189667845536,-0.0464610931936127,-0.0267752582140677,3.18479106193515e-13
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42260,0.0270802356485657,0.00601354479982302,0.0152936878409126,0.0388667834562189,6.73468990704669e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42261,0.00801026412745727,0.00828601058686289,-0.008230316622794,0.0242508448777085,0.333696008798053
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42261,0.011681835128672,0.00530661757502621,0.00128086468162066,0.0220828055757234,0.0277221241825186
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,50903,-0.0179055562857038,0.00502420753119816,-0.0277530030468522,-0.00805810952455544,0.000366074469342765
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,50903,-0.00295883502247234,0.00394987232913897,-0.0107005847875847,0.00478291474264003,0.453805638528967
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,50903,0.0124383780569321,0.00470901027978247,0.00320871790855844,0.0216680382053057,0.00826117452624512
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,50903,0.000849488623049186,0.00733798286886259,-0.0135329577999215,0.0152319350460199,0.907838889513411
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),50919,-0.0246373972134882,0.00433224622465321,-0.0331285998138085,-0.0161461946131679,1.30637360317172e-08
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,50919,-0.00456435577097477,0.00596347243638109,-0.0162527617462817,0.00712405020433216,0.444048656511968
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51006,-0.00675999925484887,0.00459192881808725,-0.0157601797382999,0.00224018122860215,0.140992483673491
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51006,-0.0105872009729489,0.00564623188026215,-0.0216538154582627,0.000479413512364897,0.0607908740161635
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51006,0.0402425685873074,0.00845736821676381,0.0236661268824504,0.0568190102921645,1.96248553257364e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51006,-0.010657996874726,0.00986553238631179,-0.0299944403518971,0.00867844660244509,0.280006374719618
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51006,0.0517856731747918,0.00975141173278382,0.0326729061785355,0.0708984401710481,1.10134801298645e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51006,-0.0100145555602001,0.0139435161357702,-0.0373438471863096,0.0173147360659095,0.472625910311623
EPHA2,Ephrin type-A receptor 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39289,-0.0134039331258711,0.00280264400112834,-0.0188971153680827,-0.00791075088365957,1.74638730938689e-06
EPHA2,Ephrin type-A receptor 2,Physical activities,X864.Number of days or week walked 10+ minutes,50630,-0.0349558260675513,0.0350494696738634,-0.103652786628324,0.033741134493221,0.318614224876982
EPHA2,Ephrin type-A receptor 2,Physical activities,X874.Duration of walks,47126,0.00111691377188544,0.0020419104395832,-0.00288523068969763,0.00511905823346852,0.584387759626972
EPHA2,Ephrin type-A receptor 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,49921,-0.0349203616950833,0.0339473381871158,-0.10145714454183,0.0316164211516638,0.303647736670919
EPHA2,Ephrin type-A receptor 2,Physical activities,X894.Duration of moderate activity,43997,0.0837611278251224,0.0410151655291985,0.00337140338789325,0.164150852262351,0.0411448004913978
EPHA2,Ephrin type-A receptor 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30061,-0.0020699785936561,0.00400986659060459,-0.0099293171112411,0.00578935992392889,0.605718253463315
EPHA2,Ephrin type-A receptor 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49927,-0.11707276629524,0.0350097409898882,-0.185691858635421,-0.048453673955059,0.000826944744030111
EPHA2,Ephrin type-A receptor 2,Physical activities,X914.Duration of vigorous activity,39247,0.00444842103600682,0.00252941304364635,-0.00050922852954003,0.00940607060155366,0.0786522288229621
